Hi Matt, as you can see in the document I have just compiled, there are thousands of pieces of research that

do not support the idea of vaccination. These are just the tip of the iceberg but people do not know about them because unfortunately, I have never once seen a fair representation of facts in the general media that supports a decision not to vaccinate. I have read incredibly well referenced books (e.g. Vaccine Safety Manual by Neil Z. Miller, which summarises hundreds of pieces of research) that report on the anti-vaccination side of the story. When googling the authors you often find that people try to discredit them by saying e.g. They have an anti-vaccination agenda and why didnt they state this? or They only present studies that support their agenda or they take issue with perceived problems of one particular study. Well that may be true, but this still does not address the many research findings. If the general public knew about this information then, at the very least, they might realise the vaccine debate is not as cut and dried as it is presented in the media and they might understand why some people choose not to vaccinate their children. SOME FINDINGS The Institute of Medicine (IOM), which is part of the National Academy of Sciences, analyzes health policies and issues advice to the US government. They're funded not just by the government but also by pharmaceutical companies and independent philanthropic organizations and individuals. They are considered a very prestigious scientific body in the world. In the last three decades, the IOM has reviewed vaccine safety several times. Their first reports came out in 1991 and 1994. However, the latest report on this issue, released in August 2011 is very significant, and many still do not understand its true importance. Over a period of three years, they reviewed over 1,000 studies on vaccines. Interestingly, they excluded studies funded by the pharmaceutical industry, although some of the studies were funded by government agencies independently. The review focused on eight vaccines: Measles, mumps and rubella vaccine Meningococcal vaccine Pneumococcal vaccine Hepatitis A-hepatitis B Varicella zoster (chickenpox) HPV vaccine Influenza vaccine Diphtheria, tetanus and acellular pertussis, also known as DTaP or Tdap Perhaps the most important thing IOM did in this review is that they looked at two categories of science: 1. Epidemiological research (large studies comparing different groups of people against each other) 2. Bench science (research into the biological mechanisms at work within cells and molecules) "This is very important because a lot of the studies that the CDC relies on as evidence that vaccines don't cause any problems are epidemiological studies. This report is important because they looked at both kinds of science. The most shocking conclusion of this report is that for more than a hundred bad health outcomes that have been reported after these eight vaccines have been given to people, they could not come to a conclusion as to whether or not those vaccines did or did not cause those adverse events!" REFERENCES Institute Of Medicine http://www.iom.edu/Reports/2011/AdverseEffects-of-Vaccines-Evidence-andCausality/Report-Brief.aspx?page=2

Some of those serious health problems included: Multiple sclerosis Lupus Encephalitis (brain inflammation) Rheumatoid arthritis Autism Encephalopathy, involving permanent brain damage Why Couldn't IOM Conclude Whether Vaccines are Causative Factors? Why is it that the IOM was unable to determine whether there was a direct causative link between vaccines and the many serious health outcomes indicated in these studies? Barbara suggests four potential explanations: 1. The studies were not available in the published literature 2. There were too few studies showing the same link 3. The available studies were methodologically unsound 4. The available studies were conflicting (i.e. there was evidence both for and against) "What I call this category is the 'We Don't Know' category. When you think about it, these vaccines are mandated for children, and yet in most instances the scientific evidence [of safety] is so poor, they don't know! When the report came out there were a lot of organizations like the American Academy of Pediatrics that came forth and said, "They didn't find causation So vaccines are safe." That's NOT what that report said at all. I think people need to understand the significance of it The category of 'We Don't Know' is a very important category" The Institute Of Medicine concludes that the evidence convincingly supports a causal relationship between some vaccines and some adverse events. Evidence Convincingly Supports a Causal Relationship The committee concludes that the evidence convincingly supports a causal relationship between some vaccines and some adverse events. As a live vaccine, the varicella zoster vaccine is linked to four specific adverse events, all due to infection from the vaccine virus strain:

Disseminated varicella infection (widespread chickenpox rash shortly after vaccination) Disseminated varicella infection with subsequent infection resulting in pneumonia, meningitis, or hepatitis in individuals with demonstrated immunodeficiencies Vaccine strain viral reactivation (appearance of chickenpox rash months to years after vaccination) Vaccine strain viral reactivation with subsequent infection resulting in meningitis or encephalitis (inflammation of the

brain) The MMR vaccine is linked to a disease called measles inclusion body encephalitis, which in very rare cases can affect people whose immune systems are compromised and usually occurs within a year of acute measles infection or vaccination. The MMR vaccine also is linked to febrile seizures, which are a type of seizure that occurs in infants and young children in association with fever. Febrile seizures are generally benign and hold no long-term consequences. Six types of vaccinesMMR, varicella zoster, influenza, hepatitis B, meningococcal, and tetanus containing vaccinesare linked to anaphylaxis. The committee also found convincing evidence of a causal relationship between injection of vaccine, independent of the antigen involved, and two types of adverse events, including syncope, or fainting, and deltoid bursitis, or frozen shoulder, characterized by shoulder pain and loss of motion. Evidence Favors Acceptance of a Causal Relationship The evidence favors acceptance of four vaccineadverse event relationships. In these cases, the evidence is strong and generally suggestive, but not firm enough to be described as convincing. These relationships include:

HPV vaccine and anaphylaxis; MMR vaccine and transient arthralgia (temporary joint pain) in female adults; MMR vaccine and transient arthralgia in children; and certain trivalent inactivated influenza vaccines used in Canada in some recent years and a mild and temporary oculorespiratory syndrome, which is characterized by conjunctivitis, facial swelling, and upper respiratory symptoms, including coughing and wheezing Clinical Infectious Diseases http://cid.oxfordjournals.org/content/early/2 012/03/13/cid.cis287

Whooping cough Eighty one percent of 2010 California whooping cough cases in people under the age of 18 occurred in those who were fully up to date on the whooping cough vaccine. Eleven percent had received at least one shot, but not the entire recommended series, and only eight percent of those stricken were unvaccinated. The vaccine's effectiveness was only 41 percent among 2to 7-year-olds and 24 percent among those aged 8-12. Percentage of B pertussis and B parapertussis cases was higher in vaccinated population compared to unvaccinated population.

Archives of Disease in Childhood http://adc.bmj.com/content/88/8/684.abstrac t http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=2779

Outbreak of pertussis in young children who had been vaccinated according to the national vaccination programme. The occurrence of smaller outbreaks of whooping cough is not unexpected; what is unexpected is an outbreak in children who had all been vaccinated against the disease with acelullar vaccine less than one year previously.

Some hypotheses for this apparent vaccine failure are: antigenic shift so that the circulating strains and vaccination strains of Bordetella pertussis diverge and vaccine efficacy is reduced other factors, alone or in combination In Australia, dangerous new strains of whooping cough bacteria were reported in March 2012. The vaccine, researchers said, was responsible. The reason for this is because, while whooping cough is primarily attributed to Bordetella pertussis infection, it is also caused by another closely related pathogen called B. parapertussis, which the vaccine does NOT protect against. Two years earlier, scientists at Penn State had already reported that the pertussis vaccine significantly enhanced the colonization of B. parapertussis, thereby promoting vaccine-resistant whooping cough outbreaks15. According to the authors: "... [V]accination led to a 40-fold enhancement of B. parapertussis colonization in the lungs of mice. Though the mechanism behind this increased colonization was not specifically elucidated, it is speculated to involve specific immune responses skewed or dampened by the acellular vaccine, including cytokine and antibody production during infection. Despite this vaccine being hugely effective against B. pertussis, which was once the primary childhood killer, these data suggest that the vaccine may be contributing to the observed rise in whooping cough incidence over the last decade by promoting B. parapertussis infection."

Centre For Infectious Disease Dynamics http://www.cidd.psu.edu/research/synopses/ acellular-vaccine-enhancement-b.parapertussis

In 2007, US health officials admitted that the pneumococcal vaccine had created superbugs that caused severe ear infections in children. Similarly bad news emerged about the hepatitis vaccine that same year, when immunologists discovered mutated vaccine-resistant viruses were causing disease. And in developing countries, even to this day, health officials are concerned that polio viruses in the vaccine may not only be mutating, but may be causing the very disease they are supposed to prevent.

Journal of Acquired Immune Deficiency Syndromes http://journals.lww.com/jaids/Fulltext/2007/1 1010/Selection_of_Hepatitis_B_Virus__HBV__ Vaccine.4.aspx News Medical http://www.newsmedical.net/news/20111108/Live-virus-usedin-polio-vaccine-can-evolve-and-infect-warnsTAU-researcher.aspx http://www.courthousenews.com/2012/06/2 7/47851.htm

Mumps Merck has recently been slapped with two separate class action lawsuits contending they lied about the effectiveness of the mumps vaccine in their combination MMR shot, and fabricated efficacy studies to maintain the illusion for the past two decades that the vaccine is highly protective. DTP and Measles interaction Fatality was increased for children ages 6 months to 17 months old, if they received the DTP with or after measles

Vaccine http://www.sciencedirect.com/science/article

vaccination. The increase was significant enough for Aaby to suggest that the DTP reduces the benefits of the measles vaccine. Chicken Pox A review of the US varicella (chickenpox) vaccination program published in May in the journal Vaccine8 concluded the vaccine has: Not proven to be cost-effective Increased the incidence of shingles Failed to provide long-term protection from the disease it targetschicken poxand Is less effective than the natural immunity that existed in the general population before the vaccine Autism A number of studies have suggested a link between autoimmune disorders and autism risk. Support comes from studies showing an increased risk of ASD in children of mothers with autoimmune disorders.1-3 Yet, not all studies agree, since at least one carefully done study found no strong link.4 Other more carefully done studies provided evidence suggesting some link. For example, in one study serum from a mother with an autistic child was found to bind immunologically with specific brain cells (Purkinje cells).5 When this serum was injected into pregnant mice, their babies demonstrated neurological changes suggestive of autistic behavior, indicating a transfer of the autoantibodies into the developing baby mouse. A number of studies have found autoantibodies in a significantly higher number of autistic children to various brain structures, such as serotonin receptors, myelin basic protein, neuron axon filament protein, nerve growth factor and cerebellar neurofilaments.6-10 It should be understood that these autoantibodies are not found in all cases and that they may develop as a result of the damage caused by the disease itself, rather than causing the disease. For example, we know that after a stroke or head injury a substantial number of people will develop autoantibodies to brain proteins. Nevertheless, the autoantibodies can worsen the damage and prolong the damaging pathology. One study found that strains of mice highly susceptible to developing autoimmune diseases were sensitive to the ASD-like behavioral effects upon mercury exposure, whereas mouse strains genetically not susceptible to autoimmunity do not develop ASD behaviors.12

/pii/S0264410X0601111X Vaccine http://www.sciencedirect.com/science/article /pii/S0264410X12007761

6. Singh VK, Rivas WH. Prevalence of serum antibodies to caudate nucleus in autistic children. Neuroscience Lett 2004; 355: 53-56. 7. Singh VK et al. Antibodies to myelin basic protein in children with autistic behavior. Brain Behavior Immunol 1993; 7: 97-103. 8. Singer HS et al. Antibrain antibodies in children with autism and their unaffected siblings. J Neuroimmunol 2006; 178: 149-155. 9. Singh VK et al. Circulating autoantibodies to neural and glial filament proteins in autism. Pediatr Neurol 1997; 17: 88-90. 10. el-Fawal HA e al. Exposure to methylmercury results in serum autoantibodies to neurotypic and gliaotypic proteins. Neurotoxicology 1996; 17: 531-539. 11. Havarinasab S et al. Immunosuppressive and autoimmune effects of thimerosal in mice. Toxicol Appl Pharmacol 2005; 204; 109121. 12. Hornig M, Chian D, Lipkin WJ. Neurotoxic effect of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 2004; 9: 833-845. http://articles.mercola.com/sites/articles/pag es/the-danger-of-excessive-vaccinationduring-brain-development.aspx

An interesting article: 'The Case for a Link to Autism Spectrum Disorders.' Notice there are 172 references to scientific research from various Journals etc.

Hep B Hepatitis B shots are part of the standard government-recommended childhood vaccination schedule, with the first dose given at 12 hours of age in the newborn nursery of most hospitals. But hepatitis B is a primarily blood-transmitted disease associated with risky lifestyle choices such as unprotected sex with multiple partners and intravenous drug use involving sharing needlesit is NOT primarily a "children's disease." For most children, the risk of a serious vaccine reaction may be 100 times greater than the risk of hepatitis B. There are more reports of serious adverse reactions in children than there are cases of childhood hepatitis B reported in America. The policy was, in part, based on the fact that adults, who are at high-risk for being infected with hepatitis B (namely, mostly those who are IV drug users or are engaging in unprotected sex with multiple partners, or prostitutes) are difficult to reach and do not get vaccinated. Infants and children are a much easier population to control, and easier to access. The thinking was that hepatitis B could be prevented in the U.S. with mass use of hep B vaccine by all infants and children so they would be protected from birth and early childhood. However, a policy that attempts to prevent an infectious disease in adolescents and adults by vaccinating infants and young children assumes the vaccine provides long lasting protection. Science has proven this is simply not the case for hepatitis B vaccine. Hepatitis B Immunity Fades After Just a Few Years Hepatitis B vaccine requires three doses for "seroprotection" (vaccine induced antibodies measured in the blood). However, all vaccines only confer temporary, partial immunity and the length of time you are protected from hepatitis B after receiving the vaccine series has gotten shorter and shorter as studies have revealed antibody levels decline much more rapidly than vaccine developers and policymakers expected. Consider these findings:
In a study involving dental healthcare workers published in the New England Journal of Medicine, it was

Australian Dental Journal http://onlinelibrary.wiley.com/doi/10.1111/j. 1834-7819.1994.tb04784.x/abstract

demonstrated that within just 5 years after vaccination, antibody levels had sharply declined or no longer existed in 42 percent of hepatitis B vaccine recipients.
A study in the American Journal of Public Health reported a significant antibody loss in 36 percent of healthcare

personnel after just 3 years.

Still other studies have found more than 60 percent of vaccine recipients are no longer protected from hepatitis B

after 5 years, and one found that HALF of vaccinated people were not protected after 4 years! So, if seroprotection is gone in less than 5 years, your baby is being subjected to ALL of the risks of the hepatitis B vaccine with NONE of the promised benefit.

A recent study looked at the immune reaction in newborn infants up to the age of one year who had received the HepB vaccine to see if their immune reaction differed from adults getting the same vaccine.27 What they found was that the infant, even after age one year, did react differently. Their antibody levels were substantially higher than adults (3-fold higher) and it remained higher throughout the study. In essence, they found that the babies responded to the vaccine by having an intense Th2 response that persisted long after it should have disappeared, a completely abnormal response. If the babys immune system remains in a Th2 mode, it has a high risk of developing an autoimmune disorder, such as eczema, asthma or other allergies. According to a study in the United Kingdom, hepatitis B vaccines may increase risks for developing multiple sclerosis (MS) by a factor of three. Researchers discovered that people showed a three-fold increase in the incidence of MS within three years of being vaccinated. They weren't able to determine if the vaccine triggers the disease in those already susceptible, or if it speeds up the onset. In addition to MS, studies also reveal a link between hepatitis B vaccines and the development of type 1 diabetes (insulindependent). In New Zealand, the incidence of type 1 diabetes rose 60 percent among children following a mass hepatitis B immunization campaign. A study published September 2009 in Annals of Epidemiology found that giving hepatitis B vaccine to infant boys more than tripled their risk for an autism spectrum disorder. This was doubly concerning because an earlier study by the same researcher group, using a different database, found the same results. Yet another study, this one published in the journal Neurology in 2009, revealed that children who received a particular hepatitis B vaccine were more likely to develop "central nervous system inflammatory demyelination" than children who did not receive the vaccine.

27. Martin OC et al. Hepatitis B immunization induces higher antibody and memory Th2 responses in new-borns than adults. Vaccine 2004; 22: 511-519.

Annals of Epidemiology http://www.sciencedirect.com/science/article /pii/S1047279709002075

Selective vaccines Studies have also shown that vaccines that cover only a few strains of a virus or bacteria that naturally have a great number of strains (some have over a hundred strains), can cause a shift in strain dominance so that the strain not included in the vaccine then becomes the dominant disease causing strain. We see this with the meningiococcal and pneumococcal vaccines

43. Pichichero ME et al. Pathogen shifts and changing cure rates for otitis media and tonsillopharyngitis. Clin Pediatr 2006; 45: 493502.

44. Moore MR et al. Impact of conjugate vaccine on community wide coverage of nonsusceptible Streptococcus in Alaska. J Inf Dis 2004; 190: 2031-2038. 45. Pichichero ME, Cary JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 2007; 298: 1772-1778. HPV There are more than 100 different strains of HPV. The vaccine is designed to protect against 4 only. The measure of vaccine given to a young girl of small body weight is the same as that give to an adult woman. Children administered high-titer vaccines can have higher infection and mortality rates. Most recently, an oncology dietitian pointed out significant discrepancies2 in a new HPV vaccine effectiveness study published in the Journal of Infectious Diseases3, which evaluated data from the National Health and Nutrition Examination Surveys (NHANES), 2003-2006 and 2007-2010. In 2007-2010, the overall prevalence of HPV was 50 percent in the vaccinated girls (14-19 years), but only 38.6 percent in the unvaccinated girls of the same age. Therefore, HPV prevalence dropped 27.3 percent in the unvaccinated girls, but only declined by 5.8 percent in the vaccinated group. In four out of five different measures, the unvaccinated girls had a lower incidence of HPV, she writes. According to Mercks own research, if you have been exposed to HPV strains 16 or 18 prior to receipt of Gardasil vaccine, you could increase your risk of precancerous lesions, or worse, by 44.6 percent. Other health problems associated with Gardasil vaccine include immune-based inflammatory neurodegenerative disorders, suggesting that something is causing the immune system to overreact in a detrimental waysometimes fatally. Between June 1, 2006 and December 31, 2008, there were 12,424 reported adverse events following Gardasil vaccination, including 32 deaths. The girls, who were on average 18 years old, died within two to 405 days after their last Gardasil injection Between May 2009 and September 2010, 16 additional deaths after Gardasil vaccination were reported. For that timeframe, there were also 789 reports of "serious" Gardasil adverse reactions, including 213 cases of permanent disability and 25 diagnosed cases of Guillain-Barre Syndrome Between September 1, 2010 and September 15, 2011, another 26 deaths were reported following HPV vaccination As of May 13, 2013, VAERS had received 29,686 reports of adverse events following HPV vaccinations, including 136 reports of death,7, as well as 922 reports of disability, and 550 life-threatening adverse events Lancet http://www.ncbi.nlm.nih.gov/pubmed/16812 65

National Center for Biotechnology Information http://www.ncbi.nlm.nih.gov/pubmed/23785 124

FDA http://www.fda.gov/ohrms/dockets/ac/06/bri efing/2006-4222B3.pdf

The reported death toll for the HPV vaccine now stands at 89. As of November 3, 2010, there were also 20,575 adverse reactions, and 352 reports of abnormal pap smears post vaccination. Keep in mind however, that it has been estimated that only 1 to 10 percent of all vaccine adverse events are ever reported

http://www.judicialwatch.org/files/document s/2010/VAERS-052009-to-092010.pdf

Published in the medical journal The Lancet in 1977 by the Department of Community Medicine in the United Kingdom also indicates that vaccines were not responsible for the decline in disease rates in that country. "There was a continuous decline [whooping cough deaths], equal in each sex, from 1937 onward. Vaccination, beginning on small scale in some places around 1948 and on a national scale in 1957, did not affect the rate of decline if it be assumed that one attack usually confers immunity, as in most major communicable diseases of childhood. ... The steady decline of whooping cough between 1930 and 1957 is predictive of a linear exponential decay characteristic of a general and progressive lessening in the volume and spread of infection among the susceptible population. With this pattern well established before 1957, there is no evidence that vaccination played a major role in the decline in incidence and mortality in the trend of events." Aluminium as an adjuvant According to a new study published in Current Medical Chemistry, children up to 6 months of age receive 14.7 to 49 times more aluminum from vaccines than the U.S. Food and Drug Administration (FDA) safety limits allow. Experimental research clearly shows that aluminum adjuvants have a potential to induce serious immunological disorders in humans. In particular, aluminum in adjuvant form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may thus have profound and widespread adverse health consequences. In our opinion, the possibility that vaccine benefits may have been overrated and the risk of potential adverse effects underestimated, has not been rigorously evaluated in the medical and scientific community. We hope that the present paper will provide a framework for a much needed and long overdue assessment of this highly contentious medical issue. Aluminum is now being implicated as interfering with a variety of cellular and metabolic processes in the nervous system and in other tissues.

Steward, Gordon T., "Vaccination Against Whooping-Cough Efficacy Versus Risks", The Lancet, January 29, 1977, pp. 234-237 http://www.thelancet.com/search/results?sea rchTerm=Vaccination+Against+WhoopingCough+Efficacy+Versus+Risks&fieldName=AllF ields&journalFromWhichSearchStarted=

Current Medicinal Chemistry http://www.ingentaconnect.com/content/ben /cmc/2011/00000018/00000017/art00011

Pediatrics http://pediatrics.aappublications.org/content/ 97/3/413.abstract http://vaers.hhs.gov/index

Federal Admission of Vaccine Risks: In 1986, Congress officially acknowledged the reality of vaccine-caused injuries and death by creating and passing The National Childhood Vaccine Injury Act (Public Law 99-660). The safety reform portion of this law requires doctors to provide parents with information about the benefits and risks of childhood vaccines prior to vaccination, and to report vaccine reactions to federal health officials. Doctors are required by law to report suspected cases of vaccine damage. To simplify and centralize this legal requisite, federal health officials established the Vaccine Adverse Event Reporting System (VAERS) -operated by the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA). It contains 1000s upon 1000s of adverse effects. The FDA recently acknowledged that 90 percent of doctors do not report

vaccine reactions. They are choosing to subvert this law by claiming the adverse event was, in their opinion, not related to the shot. In fact, every year between 12,000 and 14,000 reports of adverse reactions to vaccines are made to the FDA (data initially accessible only through the Freedom of Information Act). These figures include hospitalizations, irreversible brain damage, and hundreds of deaths. Considering that these numbers may represent just 10 percent, the true figures could be as high as 140,000 adverse events annually. However, even this figure could be conservative. According to Dr. David Kessler, former head of the Food and Drug Administration, "Only about 1 percent of serious events [adverse drug reactions] are reported to the FDA." SIDS A subset of infants may be more susceptible to SIDS shortly after being vaccinated, particularly after receiving multiple vaccines all at once. "Infant Mortality Rates Regressed Against Number of Vaccine Doses Routinely Given: Is There a Biochemical or Synergistic Toxicity?" found a high statistically significant correlation between increasing number of vaccine doses and increasing infant mortality rates Human & Experimental Toxicology http://het.sagepub.com/content/early/2011/ 05/04/0960327111407644.full.pdf+html

Pneumonia vaccinations for people over 65 are soon to be halted by the UK government, on the grounds that the injections do not save lives. Millions of people were injected with the vaccine, which was supposed to offer ten-year protection against an infection that causes pneumonia. But independent expert government advisors say the program has had 'no discernible impact' on rates of pneumococcal disease. According to the Daily Mail: "... [T]he protection provided by the vaccine is poor and not long-lasting in older people." Flu shots Giving young children flu shots appeared to have no impact on flu-related doctor visits or hospitalizations during two recent flu seasons, according to a study published in the Archives of Pediatric & Adolescent Medicine last year. The researchers concluded that "significant influenza vaccine effectiveness could not be demonstrated for any season, age, or setting" examined. A new study in The Lancet Infectious Diseases reveals that the flu vaccine prevents lab confirmed type A or type B influenza in only 1.5 out of every 100 vaccinated adults but the media is reporting this to mean "60 percent effective." It is estimated that, annually, only about 2.7% of adults get type A or type B influenza in the first place. The study showed that the use of flu vaccines appear to drop this down to about 1.2%. This is a roughly 60% drop, but that ignores the fact that the vaccine has no protective health benefit for 97.5% of adults.

https://www.gov.uk/government/publications /jcvi-advice-on-pneumococcal-polysaccharidevaccination-programme http://www.dailymail.co.uk/health/article1392594/Pneumonia-jabs-pensionersscrapped-dont-work.html?ito=feeds-newsxml National Library of Medicine http://www.ncbi.nlm.nih.gov/pubmed/18838 647?ordinalpos=10&itool=EntrezSystem2.PEnt rez.Pubmed.Pubmed_ResultsPanel.Pubmed_D efaultReportPanel.Pubmed_RVDocSum http://www.thelancet.com/journals/laninf/art icle/PIIS1473-3099%2811%2970295X/abstract

One of the largest studies ever done, found that children below the age of 2 years received no protection at all from the seasonal flu vaccine.7 The recently completed study on the effectiveness of the new H1N1 vaccine reported by the National Institute of Allergy and Infectious Disease found that 75% of small children below age 35 months received no protection from the H1N1 vaccine and that 65% of children between the ages of 3 years and 9 years received no protection from the vaccine.8 Seasonal flu vaccinations have been suspended in Australia for all children under the age of five. The suspension comes after 23 children in Western Australia were admitted to hospitals with convulsions after receiving flu injections. More than 250 children may have had adverse reactions to the vaccine, with symptoms including fever, vomiting and convulsions.

The Cochrane Collaboration: Cochrane Database of Systematic Reviews, 2006 (1). Article number CD004879. In this review that analyzed 51 studies involving more than 260,000 children and found that below age 2 years, the seasonal flu vaccine offered no protection and those older than 2 years, only 33 to 36% had protective antibody response. http://www.watoday.com.au/wa-news/fluvaccination-ban-goes-national-after-feverconvulsions-in-children-20100423-tglp.html http://www.ncbi.nlm.nih.gov/pubmed?orig_d b=PubMed&cmd=Search&term=American+jou rnal+of+respiratory+and+critical+care+medici ne%5BJour%5D+AND+527%5Bpage%5D+AND +2008%5Bpdat%5D http://archinte.jamanetwork.com/article.aspx ?articleid=486407

Research published in the American Journal of Respiratory and Critical Care Medicine also confirms that there has been no decrease in deaths from influenza and pneumonia, despite the fact that vaccination coverage among the elderly has increased from 15 percent in 1980 to 65 percent now.

A study from 2005, published in the Archives of Internal Medicine also could not find support for the use of flu vaccine to prevent deaths in the elderly. The report highlights that although immunization rates in people over 65 have increased dramatically in the past 20 years, there has not been a consequent decline in flu-related deaths. In 2007, researchers with the National Institute of Allergy and Infectious Diseases, and the National Institutes of Health published this conclusion in the Lancet Infectious Diseases: We conclude that frailty selection bias and use of non-specific endpoints such as all-cause mortality have led cohort studies to greatly exaggerate vaccine benefits.

Lancet Infectious Diseases http://www.ncbi.nlm.nih.gov/pubmed?orig_d b=PubMed&cmd=Search&term=%22The+Lanc et+infectious+diseases%22%5BJour%5D+AND +658%5Bpage%5D+AND+2007%5Bpdat%5D The Journal of Allergy and Clinical Immunology http://www.jacionline.org/article/S00916749(05)00026-6/abstract http://www.aapsonline.org/nod/newsofday29 5.php

Parents who refuse vaccinations reported less asthma and allergies in their unvaccinated children

The vaccine strain of measles virus has been found in 85% of samples taken from the guts of children with regressive autism, according to a study to be presented in Montreal, Canada, this week by Dr. Stephen Walker of the Wake Forest University

School of Medicine in North Carolina. Dr. Andrew Wakefield responds: http://www.youtube.com/watch?v=d40suCKnjbI D. Wakefield has published about 130-140 peer-reviewed papers looking at the mechanism and cause of inflammatory bowel disease, and has extensively investigated the brain-bowel connection in the context of children with developmental disorders such as autism. The story begins with the publication of a case series in the prestigious medical journal The Lancet, in February 1998. A case series essentially tells the clinical story of a group of patients with a constellation of signs and symptoms that link them together. In this case, it was a group of autistic children with gastric problems, which led to the discovery of a novel bowel disease. But rather than celebrating the discovery of a tangible, treatable problem that can help these children and others suffering with similar health issues, it became a hotly debated controversy in which Dr. Wakefields reputation was smeared. Why? Because part of the patients story included regression after a vaccine. If those children had regressed after natural chickenpox, you and I would not be sitting here now. But they didnt. They regressed after a vaccine, says Wakefield. The vaccine in question was the MMR vaccine. Since then, Dr. Wakefields study -- which suggests there may be a link between the MMR vaccine, bowel disease, and autism -- has remained one of the most controversial studies on the topic of vaccine safety. He knew he was about to enter treacherous waters when it was published, and he knew he needed to be prepared for the inevitable backlash from the vaccine industry. Says Dr. Wakefield: I decided that I was going to review all of the safety studies about measles and measles-containing vaccines because if I was going to challenge the status quo and say things that might have an adverse effect on vaccine uptake, I had to know what I was talking about. So I read all the papers, and I was absolutely appalled with the quality of the safety studies of the single [measles, mumps, and rubella vaccines], and the combined MMR vaccine in particular. His research led him to write a 250-page report, concluding that he could not support the use of the combined three-in-one 28 studies from around the world that support Dr. Wakefields controversial findings: 1. The Journal of Pediatrics November 1999; 135(5):559-63 2. The Journal of Pediatrics 2000; 138(3): 366-372 3. Journal of Clinical Immunology November 2003; 23(6): 504-517 4. Journal of Neuroimmunology 2005 5. Brain, Behavior and Immunity 1993; 7: 97-103 6. Pediatric Neurology 2003; 28(4): 1-3 7. Neuropsychobiology 2005; 51:77-85 8. The Journal of Pediatrics May 2005;146(5):605-10 9. Autism Insights 2009; 1: 1-11 10. Canadian Journal of Gastroenterology February 2009; 23(2): 95-98 11. Annals of Clinical Psychiatry 2009:21(3): 148-161 12. Journal of Child Neurology June 29, 2009; 000:1-6 13. Journal of Autism and Developmental Disorders March 2009;39(3):405-13

MMR vaccine. In his opinion it simply was not safe. This recommendation was made public during a press conference in February of 1998, at which time single vaccines were still available in the UK. But in order to protect MMR vaccine policy, in September of that same year, the British government withdrew the importation license for the single measles vaccine, leaving parents without any choice they either had to vaccinate their children with the triple MMR vaccine, or not vaccinate. The result? A decline in vaccination, and an increase in measles outbreaks But rather than acknowledging the lack of safe options, Dr. Wakefield was singled out as an anti-vaccine advocate whose recommendations caused a decline in children being vaccinated, and hence responsible for the increase in measles.

14. Medical Hypotheses August 1998;51:133-144. 15. Journal of Child Neurology July 2000; ;15(7):429-35 16. Lancet. 1972;2:883884. 17. Journal of Autism and Childhood Schizophrenia January-March 1971;1:48-62 18. Journal of Pediatrics March 2001;138:366-372. 19. Molecular Psychiatry 2002;7:375-382. 20. American Journal of Gastroenterolgy April 2004;598-605. 21. Journal of Clinical Immunology November 2003;23:504-517. 22. Neuroimmunology April 2006;173(12):126-34. 23. Prog. Neuropsychopharmacol Biol. Psychiatry December 30 2006;30:14721477. 24. Clinical Infectious Diseases September 1 2002;35(Suppl 1):S6-S16 25. Applied and Environmental Microbiology, 2004;70(11):6459-6465 26. Journal of Medical Microbiology October 2005;54:987-991 27. Archivos venezolanos de puericultura y

pediatra 2006; Vol 69 (1): 19-25. 28. Gastroenterology. 2005:128 (Suppl 2);Abstract-303

1 2 3 4

Herd Immunity

Typically, vaccine promoters will stress the importance of compliance with the vaccine schedule that requires multiple doses of a vaccine in order to create and maintain vaccine induced "herd immunity," because a vaccine is never 100 percent effective. However, they never quite seem to be able to explain why the majority of outbreaks occur in areas that are thought to HAVE herd immunity status, i.e. where the majority of people are vaccinated and "should" therefore never get the disease. The problem is that there is, in fact, such a thing as natural herd immunity. But what has happened is that public health officials have taken this natural phenomenon and assumed that vaccine induced herd immunity is the same as disease induced herd immunity and it is not the same. The science clearly shows that there's a big difference between naturally developed herd immunity and vaccine-induced herd immunity in a population.

CHOP Parents PACK August 15, 2012 GreenMedInfo.com August 29, 2012 Clinical Infectious Diseases March 15, 2012

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap)
5

CDC Morbidity and Mortality Weekly Report, Pertussis epidemic Washington 2012, July 20, 2012 / 61(28);517-522
6 7 8

Investigative News Source August 15, 2012 KPBS August 15, 2012

"The original concept of herd immunity is that when a population experiences the natural disease natural immunity would be achieved a robust, qualitatively superior natural herd immunity within the population, which would then protect other people from getting the disease in other age groups. It's the way infectious diseases workBut the vaccinologists have adopted this idea of vaccine induced herd immunity.
The problem with it is that all vaccines only confer temporary protection Pertussis vaccine is one the best examples Pertussis vaccines have been used for about 50 to 60 years, and the organism has started to evolve to become vaccine resistant. I think this is not something that's really understood generally by the public: Vaccines do not confer the same type of immunity that natural exposure to the disease does."

The Journal of Pediatrics July 23, 2012 [Epub ahead of print]

9

Canadian Journal of Public Health May-June 1991;82(3):189-90

10 11

CHOP Vaccine Education Center March 2012

New England Journal of Medicine September 27, 2007

12 13

GreenMedInfo.com August 27, 2012 CHOP Vaccine Brochure Spring 2012

Vaccine professionals would like you to believe they are the same, but they're qualitatively two entirely different types of immune responses. "In most cases natural exposure to disease would give you a longer lasting, more robust, qualitatively superior immunity because it gives you both cell mediated immunity and humoral immunity. Humoral is the antibody production. The way you

measure vaccine-induced immunity is by how high the antibody titers are. (How many antibodies you have, basically.) But the problem is that cell mediated immunity is very important as well. Most vaccines evade cell mediated immunity and go straight for the antibodies, which is only one part of immunity. That's been the big problem with the production of vaccines."

Unvaccinated Population Falsely Blamed for Ineffective Vaccines Recent disease outbreaks were traced back to personal belief exemptions... Really? That's just not reality, and if you take the time to look into the truthfulness of that statement, you'll see it simply does not hold up. Many outbreaks of pertussis (whooping cough), measles, and mumps have occurred primarily in people who were vaccinated, and no one seems to be able to fully explain how that is the fault of those who are unvaccinated... If the vaccine theory was correct, these people should have been protected because they were vaccinated. Published studies into the outbreaks have revealed that a lot of the blame should be placed on ineffective vaccines not on the unvaccinated minority. Consider the following findings about the last two whooping cough (pertussis) outbreaks. In 2010, the largest outbreak of whooping cough in over 50 years occurred in California. Around that same time, a scare campaign was launched in California by Pharma-funded medical trade associations, state health officials and national media, targeting people opting out of receiving pertussis vaccine, falsely accusing them of causing the outbreak. However, research published in March of this year3 shows that 81 percent of 2010 California whooping cough cases in people under the age of 18 occurred in those who were fully up to date on the whooping cough vaccine. Eleven percent had received at least one shot, but not the entire recommended series, and only eight percent of those stricken were unvaccinated. According to the authors: "This first detailed analysis of a recent North American pertussis outbreak found widespread disease among fully vaccinated older children. Starting approximately three years after prior vaccine dose, attack rates markedly increased, suggesting inadequate protection or durability from the acellular vaccine." [Emphasis mine]

B. pertussis whooping cough is a cyclical disease with natural increases that tend to occur every 4-5 years, no matter how high the vaccination rate is in a population using DPT/DTaP or Tdap vaccines on a widespread basis. Whole cell DPT vaccines used in the U.S. from the 1950's until the late 1990's were estimated to be 63 to 94 percent effective and studies showed that vaccine-acquired immunity fell to about 40 percent after seven years. In the study cited above, the researchers noted the vaccine's effectiveness was only 41 percent among 2- to 7-year-olds and a dismal 24 percent among those aged 8-12. With this shockingly low rate of DTaP vaccine effectiveness, the questionable solution public health officials have come up with is to declare that everybody has to get three primary shots and three follow-up booster shots in order to get long-lasting protection4 and that's provided the vaccine gives you any protection at all! The Washington State Secretary of Health also declared a pertussis epidemic on April 3, 2012, in response to a 1,300 percent increase in pertussis cases compared to 2011.5 Scientists are now considering adding a seventh inoculation6, in order to boost protection against whooping cough. According to a recent article and video by KPBS:7 "New research confirms the whooping cough vaccine is failing at a higher rate than expected, and scientists are considering adding a seventh dose to the national immunization schedule published by the Centers for Disease Control and Prevention. Two recent studies8 have found the majority of people getting sick are up to date with their immunizations.

Mumps and Measles Vaccines are Also Failing

Mumps: In 2010, more than 1,000 people in New Jersey and New York were also sickened with mumps. In the US, children typically receive their mumps vaccination as part of the Measles, Mumps, and Rubella (MMR) vaccine. The U.S. Centers for Disease Control and Prevention (CDC) advises children to receive their first dose between 12 and 18 months, and their second between the ages of 4 and 6. This vaccine is supposed to improve immunity to measles, mumps and rubella yet 77 percent of the 1,000+ who came down with mumps were vaccinated. Similarly, in 2006, when mumps infected more than 6,500 people in the United States, cases occurred primarily among college students who had received two doses of MMR vaccine. At that time, just about the only people who were truly immune to mumps were older Americans who had recovered from mumps as children, and therefore had received natural, lifelong immunity.

Measles The 1989 measles epidemic in the region of Quebec was largely attributed to incomplete vaccination coverage until a study9 into the outbreak disclosed that the outbreak occurred in a population that had 99 percent vaccination coverage. The researchers concluded that: "Incomplete vaccination coverage is not a valid explanation for the Quebec City measles outbreak."

Conflicts of Interest Not Science Influence Most Vaccine Recommendations The CHOP newsletter is delivered by email periodically to anyone who signs up for it, and almost always contains advice on getting all children vaccinated. The Vaccine Education Center10 at CHOP says it's funded by endowed chairs and "does not receive support from pharmaceutical companies." But it neglects to mention that the hospital indirectly benefits from drug company money that helps fund endowed chairs like Merck's Maurice R. Hilleman Professor of Vaccinology, which is currently held by Paul Offit11, who not only is very public about his belief that infants could theoretically safely handle 10,000 vaccines all at once; he also openly opposes personal belief vaccine exemptions.12 Rarely is it mentioned that Offit has a financial stake in the vaccine industry, as he invented one of the vaccines CHOP promotes. He's also served on the scientific advisory board of Merck. Offit's personal beliefs about forcing people to involuntarily use vaccines, which violates the informed consent ethic in medicine, along with the inaccurate statements he makes about vaccine safety, which are not backed by solid scientific evidence, are echoed throughout CHOP's pro-forced vaccination propaganda. For example, one of their Q&A brochures13 answers the question: Can too many vaccines overwhelm an infant's immune system? with the following statement: "No. Compared to the immunological challenges that infants handle every day, the challenge from the immunological components in vaccines is minuscule. Babies begin dealing with immunological challenges at birth. The mother's womb is a sterile environment, free from viruses, bacteria, parasites and fungi. But after babies pass through the birth canal and enter the world, they are immediately colonized with trillions of bacteria, which means that they carry the bacteria on their bodies but aren't infected by them. These bacteria live on the skin, nose, throat and intestines. To make sure that colonizing bacteria don't invade the bloodstream and cause harm, babies constantly make antibodies against them. ...Given that infants are colonized with trillions of bacteria, that each bacterium contains between 2,000 and 6,000 immunological components and that infants are infected with numerous viruses, the challenge from the 150 immunological components in vaccines is minuscule compared to what infants manage every day."

This is an astounding comparison and shockingly ignorant of foundational physiology. Not only do these ignorant statements dismiss and disparage the role of beneficial gut bacteria which we now know are absolutely essential and vital for human health and well-being and characterize normal gut bacteria as potentially harmful, but there is a false characterization of the immunological challenge posed by multiple vaccines, each of which can contain either live or killed viruses and a number of different adjuvants and chemicals, injected into the tiny body of an infant. CHOP even takes Offit's ridiculous claim that infants can safely handle 10,000 vaccines at one time to brand new heights, stating that:14 "The purpose of vaccines is to prompt a child's body to make antibodies, which work by preventing bacteria and viruses from reproducing themselves and causing disease. So, how many different antibodies can babies make? The best answer to this question came from a Nobel Prize-winning immunologist at the Massachusetts Institute of Technology named Susumu Tonegawa, who first figured out how people make antibodies. Tonegawa discovered that antibodies are made by rearranging and recombining many different genes, and found that people can make about 10 billion different antibodies. Given the number of antibody-producing cells in a child's bloodstream, and the number of immunological components contained in vaccines, it is reasonable to conclude that babies could effectively make antibodies to about 100,000 vaccines at one time."

The Difference Between Natural and Vaccine-Induced Immunity Many still believe vaccines provide identical immunity to that obtained when you are naturally exposed to an infection, This widespread misconception needs to be corrected. The presumed result of a vaccination is to help you build immunity to potentially harmful organisms that cause disease. What many fail to appreciate is that your body's immune system is already designed to do this in response to naturally-occurring infectious agents that you are constantly exposed to throughout life. One major difference between vaccine-induced immunity and natural immunity stems from how you're exposed to these organisms. Most organisms that cause infection enter your body through the mucous membranes of your nose, mouth, lungs or your digestive tract. These mucous membranes have their own immune system, called the secretory IgA immune system. It is a different system from the one activated when a vaccine is injected into your body. Your IgA immune system is your body's first line of defense

and its job is to address the infectious microorganism at their entry points, thus reducing or even eliminating the need for activation of your body's entire immune system. However, when a laboratory altered or created infectious microorganism is injected into your body with a vaccine and, especially when combined with an immune adjuvant, such as aluminum, your IgA immune system is bypassed, stimulating your immune system to mount a very strong inflammatory response. Vaccines can also trigger such a strong inflammatory response that the inflammation becomes chronic and leads to chronic illness or disability. (People with a personal or family history of severe allergy or autoimmunity should be cautious about vaccination because they already have a genetic predisposition to inflammatory responses that do not resolve and can lead to chronic health problems.) Injecting these lab-altered microorganisms into your body in an attempt to provoke an atypical, temporary immunity is clearly not the same way your body develops naturally-acquired immunity. Your immune system simply was not designed to be injected with lab altered disease-causing organisms in this manner. While I am a great fan and avocate of technology it is very clear to me that this is one reason why vaccines almost always only provide a much more temporary immunity compared to naturally acquired immunity. Additionally, this plays a large role in why vaccines have the potential to do serious damage to your health. Since vaccines bypass your natural first-line defense (your lgA immune system), they are clearly inferior to natural immunity and fail to provide the same kind of long lasting protection from future disease as they provide typically inferior immunity compared to that your body would acquire by experiencing and healing from the natural disease. In the case of mumps, for instance, immunity is typically permanent for those who contract the disease during childhood. Ways of presenting information: Some clinical trials are only able to show a meaningful benefit because they focus on relative risk reduction rather than absolute risk reduction. What's the difference?

Relative risk reduction is calculated by dividing the absolute risk reduction by the control event rate Absolute risk reduction is the decrease in risk of a treatment in relation to a control treatment

In plain English, here's what that means: let's say you have a study of 200 women, half of whom take a drug and half take a

placebo, to examine the effect on breast cancer risk. After five years, two women in the drug group develop breast cancer, compared to four who took the placebo. This data could lead to either of the following headlines, and both would be correct: "New Miracle Drug Cuts Breast Cancer Risk by 50%!" "New Drug Results in 2% Drop in Breast Cancer Risk!" How can this be? The Annie Appleseed Project explains: "The headlines represent two different ways to express the same data. The first headline expresses the relative risk reduction the two women who took the drug (subjects) and developed breast cancer equal half the number (50%) of the four women who took the placebo (controls) and developed breast cancer. The second headline expresses the absolute risk reduction 2% of the subjects (2 out of 100) who took the drug developed breast cancer and 4% of the controls (4 out of 100) who took the placebo developed breast cancer an absolute difference of 2% (4% minus 2%)." You can now see why clinical trials, especially those funded by drug companies, will cite relative risk reductions rather than absolute risk reductions, and as a patient you need to be aware that statistics can be easily manipulated. As STATS at George Mason University explains: "An important feature of relative risk is that it tells you nothing about the actual risk."

More research.

Vaccines and Nervous System Changes:

Bondarev, VN et al, "The Changes of the Nervous System in Children After Vaccination", Pediatria, Jun 1969; 48:20-24. Ehrengut W, "Central nervous sequelae of vaccinations," Lancet 1986 May 31;1(8492):1275-1276. Provvidenza, G et al, [On a Case of Benign Acute Cerebellar Ataxia in Childhood], Arch Ital Sci Med Trop, 43:189-194, Apr 1962. Katsilambros, L, "[The Phenomenom of Apathy in Man and Animals After the Injection of Viruses in Very High Doses. Clinical Data]", Rev Med Moyen

Orient, 20:539-546, Nov - Dec 1963. Vaccines and Autism:

Eggers, C, "Autistic Syndrome (Kanner) And Vaccinations against Smallpox", Klin Paediatr, Mar 1976, 188(2):172-180. Kiln MR, "Autism, inflammatory bowel disease, and MMR vaccine." Lancet 1998 May 2;351(9112):1358. Selway, "MMR vaccination and autism 1998. Medical practitioners need to give more than reassurance." BMJ 1998 Jun 13;316(7147):1824. Nicoll A, Elliman D, Ross E, "MMR vaccination and autism 1998," MJ 1998 Mar 7;316(7133):715-716. Lindley K J, Milla PJ, "Autism, inflammatory bowel disease, and MMR vaccine."Lancet 1998 Mar 21;351(9106):907-908. Bedford H, et al, "Autism, inflammatory bowel disease, and MMR vaccine." Lancet 1998 Mar 21;351(9106):907. Vijendra K. Singh, Sheren X. Lin, and Victor C. Yang, "Serological Association of Measles Virus and Human Herpesvirus-6 with Brain Autoantibodies in Autism," Clinical Immunology and Immunopathology, Oct 1998, Vol. 89, No. 1, p 105-108. ["None of the autistic children in the study had measles in the past, but all had the MMR" stated David Whalgren.

Vaccines and Demyelination:

Herroelen, L et al, "Central-Nervous-System Demyelination After Immunization with Recombinant Hepatitis B Vaccine", Lancet, Nov 9, 1991, 338(8776):1174-1175. Kaplanski G, Retornaz F, Durand J, Soubeyrand J, "Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype." J Neurol Neurosurg Psychiatry 1995 Jun; 58(6):758-759. Matyszak MK, Perry VH, "Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette-Guerin." Neuroscience 1995 Feb;64(4):967-977. Tornatore CS, Richert JR, "CNS demyelination associated with diploid cell rabies vaccine." Lancet 1990 Jun 2;335(8701):1346-1347. Adams, JM et al, "Neuromyelitis Optica: Severe Demyelination Occurring Years After Primary Smallpox Vaccinations", Rev Roum Neurol, 1973, 10:227-231. In 1988, Dietrich used MRI to show that developmentally delayed children had alterations in their myelin. Coulter described that central nervous system damage can be exhibited as abnormal behavior of the child. In 1935, Thomas Rivers, experimental allergic encephalitis (EAE) can be the result of a viral or bacterial infection of the nervous system. "The fact of the matter is that it is a matter of record that it was known that vaccination produced encephalitis since 1926." The authors stated, "In regions in which there is no organized vaccination of the population, general paralysis is rare. ... It is impossible to deny a connection between vaccinations and the encephalitis (brain damage) which follows it." Vaccines have been linked to seizures, convulsions and epilepsy.

Vaccines and Seizures:

Hirtz DG, Nelson KB, Ellenberg J H, "Seizures following childhood immunizations", Pediatr 1983 Jan; 102(1):14-18. Cherry JD, Holtzman AE, Shields WD, Buch D, Nielsen, "Pertussis immunization and characteristics related to first seizures in infants and children,"J Pediatr 1993 Jun;122(6):900-903. Coplan J, "Seizures following immunizations," J Pediatr 1983 Sep;103(3):496. Barkin RM, Jabhour JT, Samuelson J S, "Immunizations, seizures, and subsequent evaluation," JAMA 1987 Jul 10;258(2):201. Griffin MR, et al, "Risk of seizures after measles-mumps-rubella immunization," Pediatrics 1991 Nov;88(5):881-885.

Griffin MR, et al, "Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine," JAMA 1990 Mar 2330;263(12):1641-1645. Cizewska S, Huber Z, Sluzewski W, "[Prophylactic inoculations and seizure activity in the EEG]," Neurol Neurochir Pol 1981 Sep-Dec;15(5-6):553-557. [Article in Polish] Huttenlocher PR, Hapke RJ, "A follow-up study of intractable seizures in childhood." Ann Neurol 1990 Nov; 28(5):699-705. Blumberg DA, "Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed study of children with seizures, hypotonic-hypo-responsive episodes, high fevers, and persistent crying."Pediatrics 1993 Jun; 91(6):1158-1165.

Vaccines and Convulsions:

Prensky AL, et al, "History of convulsions and use of pertussis vaccine," J Pediatr 1985 Aug; 107(2):244-255. Baraff LJ, "Infants and children with convulsions and hypotonic-hypo-responsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation," Pediatrics 1988 Jun; 81(6):789-794. Jacobson V, "Relationship of pertussis immunization to the onset of epilepsy, febrile convulsions and central nervous system infections: a retrospective epidemiologic study," Tokai J Exp Clin Med 1988;13 Suppl: 137-142. Cupic V,et al, "[Role of DTP vaccine in the convulsive syndromes in children]," Lijec Vjesn 1978 Jun; 100(6):345-348. [Article in Serbo-Croatian (Roman)] Pokrovskaia NIa, "[Convulsive syndrome in DPT vaccination (a clinico-experimental study)]," Pediatriia 1983 May;(5):37-39. [Article in Russian]

Vaccines and Epilepsy:

Ballerini, Ricci, B, et al, "On Neurological Complications of Vaccination, With Special Reference to Epileptic Syndromes," Riv Neurol, Jul-Aug 1973, 43:254258. Wolf SM, Forsythe A, "Epilepsy and mental retardation following febrile seizures in childhood," Acta Paediatr Scand 1989 Mar;78(2):291-295.

Vaccines and Brain Swelling:

Iwasa, S et al, "Swelling of the Brain in Mice Caused by Pertussis ... Quantitative Determination and the Responsibility of the Vaccine", Jpn J Med Sci Biol, 1985 , 38(2):53-65. Mathur R, Kumari S, "Bulging fontanel following triple vaccine." Indian Pediatr 1981 Jun;18(6):417-418. Barry W, Lenney W, Hatcher G, "Bulging fontanelles in infants without meningitis." Arch Dis Child 1989 Apr;64(4):635-636. Shendurnikar N, "Bulging fontanel following DPT" Indian Pediatr 1986 Nov;23(11):960. Gross TP, Milstien JB, Kuritsky JN, "Bulging fontanelle after immunization with diphtheria-tetanus-pertussis vaccine and diphtheria-tetanus vaccine." J Pediatr 1989 Mar;114(3):423-425. Jacob J, Mannino F, "Increased intracranial pressure after diphtheria, tetanus, and pertussis immunization." Am J Dis Child 1979 Feb;133(2):217-218. Dugmore, WN, "Bilateral Oedema at the Posterior Pole. Hypersensitivity Reaction to Alavac P injection." Br J Ophthalmol, Dec 1972, 55:848-849.

Vaccines and Neurological Damage

Nedar P R, and Warren, R J, "Reported Neurological Disorders Following Live Measles Vaccine", 1968, Ped, 41:997-1001. Paradiso, G et al, "Multifocal Demyelinating Neuropathy after Tetanus Vaccine", Medicina (B Aires), 1990, 50(1):52-54. Landrigan, PJ, Whitte, J, "Neurologic Disorders Following Live Measles-virus Vaccination", JAMA, Mar 26, 1973, v223(13):1459-1462. Turnbull, H M, "Encephalomyelitis Following Vaccination", Brit Jour Exper Path, 7:181, 1926. Kulenkampff, M et al, "Neurological Complications of Pertussis Inoculation", Arch Dis Child, 1974, 49:46. Strom, J, "Further Experience of Reactions, Especially of a Cerebral Nature in Conjunction with Triple Vaccination", Brit Med Jour, 1967, 4:320-323. Berg, J M, "Neurological Complications of Pertussis Immunization," Brit Med Jour, July 5,1958; p 24. Bondarev, VN et al, "The Changes of the Nervous System in Children After Vaccination", Pediatria, Jun 1969; 48:20-24. Badalian, LO, "Vaccinal Lesions of the Nervous System in Children," Vop Okhr Materin Dets, Dec 1959, 13:54-59 Lorentz, IT, et al, "Post-Vaccinal Sensory Polyneuropathy with Myoclonus", Proc Aust Ass Neurol, 1969, 6:81-86. Trump, R C, White, T R, "Cerebellar Ataxia Presumed Due To Live Attenuated Measles Virus Vaccine," JAMA, 1967, 199:165-166. Allerdist, H, "Neurological Complications Following Measles Vaccination", Inter Symp, Brussels, 1978, Development Biol Std, Vol 43, 259-264. Finley, K H, "Pathogenesis of Encephalitis Occurring With Vaccination, Variola and Measles, Arch Neur and Psychologist, 1938; 39:1047-1054. Froissart, M et al, "Acute Meningoencephalitis Immediately after an Influenza Vaccination", Lille Med, Oct 1978, 23(8):548-551. Pokrovskaia, Nia, et al, "Neurological Complications in Children From Smallpox Vaccination", Pediatriia, Dec 1978, (12):45-49. Allerdist, H, "Neurological Complications Following Measles Virus Vaccination. Evaluation of the Cases seen Between 1971-1977", Monatsschr Kinderheilkd, Jan 1979, 127(1): 23-28. Ehrengut, W et al, "On Convulsive Reactions Following Oral vaccination Against Polio", Klin Paediatr, May 1979, 191(3):261-270. Naumova, R P, et al, "Encephalitis Developing After Vaccination without a Local Skin Reaction", Vrach Delo, Jul 1979, (7):114-115. Goswamy, BM, "Neurological Complications After Smallpox Vaccination", J Ass Phys India, Jan 1969, 17:41-43. Schchelkunov, SN et al, "The Role of Viruses in the Induction of Allergic Encephalomyelitis," Dokl Akad Nauk SSSR, 1990,315(1):252-255. [Vaccines contain viruses, too] Walker AM, "Neurologic events following diphtheria-tetanus-pertussis immunization," Pediatrics 1988 Mar;81(3):345-349. Shields WD, et al, "Relationship of pertussis immunization to the onset of neurologic disorders: a retrospective epidemiologic study," J Pediatr 1988 Nov; 113(5):801-805. Wilson J, "Proceedings: Neurological complications of DPT inoculation in infancy," Arch Dis Child 1973 Oct; 48(10):829-830. Iakunin IuA, "[Nervous system complications in children after preventive vaccinations]," Pediatriia 1968 Nov; 47(11):19-26. [Article in Russian] Greco D, et al, "Case-control study on encephalopathy associated with diphtheria-tetanus immunization in Campania, Italy," Bull World Health Organ 1985;63(5):919-925. Ehrengut W at Institute of Vaccinology and Virology, Hamburg, Germany states, "Bias in the evaluation of CNS complications following pertussis immunization are the following: 1) Notifications of post-immunization adverse events, 2) Publications by vaccine producers on the frequency of adverse reactions, 3) Comparison of permanent brain damage after DPT and DT immunization, 4) Pro-immunization, 5) Immunization associated viral encephalitis, 6) Accuracy of statistics, 7) Personal. A review of these points indicates an underestimation of CNS complications after pertussis immunization." Reference: Ehrengut W, "Bias in evaluating CNS complications following pertussis immunization." Acta Paediatr Jpn, 1991 Aug; 33(4):421-427. The Mumps Vaccine and Neurological Disorders:

Bottiger, M., et al. "Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps and rubella." British Medical Journal

1987; 295:264-67. Thomas, E. "A case of mumps meningitis: A complication of vaccination?" Journal of the Canadian Medical Association 1988; 138:135. Champagne, S., et al. "A case of mumps meningitis: a post-immunization complication?" Canadian Disease Weekly Report 1988; 13-35:155-156. Ehrengut, W. "Mumps vaccine and meningitis." Lancet 1989; 2:751. Von Muhlendahl, K.E. "Mumps meningitis following measles, mumps and rubella immunisations." Lancet (August 12, 1989), p. 394. Cizman, M., et al. "Aseptic meningitis after vaccination against measles and mumps." Pediatric Infectious Disease Journal 1989; 8:302-308. McDonald, J., et al. "Clinical and epidemiological features of mumps meningo-encephalitis and possible vaccine-related disease." Pediatric Infectious Disease Journal (November 1989), pp. 751-754. Gray, J.A., et al. "Mumps meningitis following measles, mumps, and rubella immunisation." Lancet 1989; i:98. Gray, J.A., et al. "Mumps vaccine meningitis." Lancet 1989; i:927. Murray, M.W., et al. "Mumps meningitis after measles, mumps, and rubella immunisation." Lancet 1989; ii:877. \

"Mumps meningitis and MMR vaccination." [Editorial] Lancet 1989; ii:1015-1016. Forsey, T., et al. "Mumps viruses and mumps, measles, and rubella vaccine." British Medical Journal 1989; 299:1340. Forsey, T., et al. "Mumps vaccines and meningitis." Lancet 1992; 340:980. Miller, E., et al. "Risk of aseptic meningitis after measles, mumps, and rubella vaccine in U.K. children." Lancet 1993; 341:979. Sawada, et al. Lancet 1993; 342:371. The Mumps Vaccine and Meningitis Attack Rates:

Sugiura, A., et al. "Aseptic meningitis as a complication of mumps vaccination." Journal of Pediatric Infectious Diseases 1991; 10:209-213. [1 case of meningitis per 2000 doses of mumps vaccine.] Fujinaga, T., et al. "A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine." Journal of Pediatric Infectious Diseases 1991; 10:204-209. [6 cases of meningitis per 2000 doses of mumps vaccine.] Colville, A., et al. "Mumps meningitis and measles, mumps, and rubella vaccine." Lancet 1992; 340:786. [1 case of meningitis per 3800 doses of mumps vaccine.] The Mumps Vaccine and Diabetes:

Sultz, H.A., et al. "Is mumps virus an etiologic factor in juvenile diabetes mellitus?" Journal of Pediatrics 1975; 86:654-656. Sinaniotis, C.A., et al. "Diabetes mellitus after mumps vaccination (letter)." Archives of Disease in Childhood 1975; 50:749-750. Quast, U., et al. "Vaccine-induced mumps-like diseases." Developments in Biological Standardization 1979; 43:269-272. Otten, A., et al. "Mumps, mumps vaccination, islet cell antibodies and the first manifestation of diabetes mellitus type I." Behring Institute Mitteilungen 1984; 75:83-88. Helmke, K., et al. "Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination." Diabetologia 1986; 29:30-33.

Fescharek, R., et al. "Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects." Vaccine 1990; 8:446-456. Pawlowski, B., et al. "Mumps vaccination and type-1 diabetes." Deutsche Medizinische Wochenschrift 1991; 116:635. Adler, J.B., et al. "Pancreatitis caused by measles, mumps, and rubella vaccine." Pancreas 1991; 6:489-490. Albonico, H., Klein, P., et al. "The immunization campaign against measles, mumps and rubella -- coercion leading to a realm of uncertainty: medical objections to a continued MMR immunization campaign in Switzerland." JAM 1992; 9(1). [180 European medical doctors jointly noted that the mumps vaccine "can trigger diabetes, which only becomes apparent months after vaccination."] Atypical Mumps:

Gunby, P. "'Atypical' mumps may occur after immunization." Journal of the American Medical Association 1980; 243(23): 2374-75. Family Practice News (July 15, 1980), p. 1. The Mumps Vaccine is Often Ineffective and Alters the Epidemiology of the Disease (It Causes Higher Rates of Mumps in High-Risk Groups):

Fiumara, N.J., et al. "Mumps outbreak in Westwood, Massachusetts -- 1981." MMWR 1982; 33(29):421-430. Kaplan, K.M., et al. "Further evidence of the changing epidemiology of a childhood vaccine-preventable disease." Journal of the American Medical Association 1988; 260(10):1434-1438. Briss, P. A., et al. "Sustained transmission of mumps in a highly vaccinated population: assessment of vaccine failure and waning vaccine-induced immunity." Journal of Infectious Diseases 1994; 169:77-82. Sawada, et al. Lancet 1993; 342:371. CDC. "Mumps -- United States, 1985-1988." MMWR 1989; 38:101-05. Girls who contract mumps naturally during childhood are less likely to develop ovarian cancer in later life:

West, R. "Epidemiologic study of malignancies of the ovaries." Cancer 1966; 19:1001-1007. Wynder, E., et al. "Epidemiology of cancer of the ovary." Cancer 1969; 23:352. Newhouse, M., et al. "A case control study of carcinoma of the ovary." Brit J Prev Soc Med 1977; 31:148-53. McGowan, L., et al. "The woman at risk from developing ovarian cancer." Gynecol Oncol 1979; 7:325-344. The MMR Vaccine:

Albonico, H., Klein, P., et al. "The immunization campaign against measles, mumps and rubella -- coercion leading to a realm of uncertainty: medical objections to a continued MMR immunization campaign in Switzerland." JAM 1992; 9(1). [180 European medical doctors oppose the use of MMR.] Wakefield, A., et al. "Measles, mumps and rubella vaccine: through a glass, darkly." Adverse Drug Reaction and Toxicologica Reviews 2000; 19(4):265-283. Templeton, S. "MMR vaccine should not have been licensed." Sunday Herald (London: December 10, 2000). [Article] Petrovic, M., et al. "Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals." British Medical Journal 2001; 322:82-85. [Doctors and nurses do not recommend it.]

BBC News. "Why Japan stopped using MMR," (February 8, 2002). www.news.bbc.co.uk/hi/english/world/asia-pacific/newsid_1808000/1808316.stm The MMR (or Measles) Vaccine and Autism:

Oleske, J. "Elevated rubeola [measles] titers in autistic children." Abstract presented by D. Zecca and Dr. Graffino at an NIH meeting (September 23, 1997). As quoted by Richard Gallup in "Autism and autoimmunity." www.chiroweb.com/archives/18/14/10.html (April 15, 2002.) Fudenberg, H.H. "Dialysable lymphocyte extract (DlyE) in infantile onset autism: a pilot study." Biotherapy 1996; 9:143-147. Gupta, S. "Immunology and immunologic treatment of autism." Proceedings of the National Autism Association, Chicago 1996: 455-460. Wakefield, A.J., et al. "Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children." Lancet 1998; 351:637641. Yazbak, F.E. "Autism: Is there a vaccine connection? Part I. Vaccination after delivery." 1999. www.garynull.com/documents/autism99b.htm Yazbak, F.E. "Autism: Is there a vaccine connection? Part II. Vaccination around pregnancy." 1999. www.garynull.com/documents/autism99b2.htm Yazbak, F.E. "Autism: Is there a vaccine connection? Part III. Vaccination around pregnancy, the sequel." 2000. www.garynull.com/documents/autism99b3.htm "Autism: Present Challenges, Future Needs -- Why the Increased Rates?" Government Reform Committee Hearing, Washington, DC. (April 6, 2000.) "Autism: Why the Increased Rates? A One-Year Update." Government Reform Committee Hearing, Washington, DC. (April 25-26, 2001.) "The Autism Epidemic: Is the NIH and CDC Response Adequate?" Government Reform Committee Hearing, Washington, DC. (April 18, 2002.) "The Status of Research into Vaccine Safety and Autism." Government Reform Committee Hearing, Washington, DC. (June 19, 2002.) Kawashima, K., et al. "Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism." Digestive Diseases and Sciences (April 2000); 45:723-729. Reuters Medical News. "Measles persistence confirmed in some patients with IBD, autistic enterocolitis." (June 20, 2000). www.id.medscape.com/reuters/prof/2000/06/06.20/20000620scie001.html Wakefield, A.J. et al. "Enterocolitis in children with developmental disorders." American Journal of Gastroenterology 2000; 95(9):2154-2156. Wakefield, A., et al. "Measles, mumps and rubella vaccine: through a glass, darkly." Adverse Drug Reaction and Toxicologica Reviews 2000; 19(4):265-283. Kiln MR, "Autism, inflammatory bowel disease, and MMR vaccine." Lancet 1998 May 2;351(9112):1358. Selway, "MMR vaccination and autism 1998. Medical practitioners need to give more than reassurance." BMJ 1998 Jun 13;316(7147):1824. Nicoll A, Elliman D, Ross E, "MMR vaccination and autism 1998," MJ 1998 Mar 7;316(7133):715-716. Lindley K J, Milla PJ, "Autism, inflammatory bowel disease, and MMR vaccine."Lancet 1998 Mar 21;351(9106):907-908. Bedford H, et al, "Autism, inflammatory bowel disease, and MMR vaccine." Lancet 1998 Mar 21;351(9106):907. *Vijendra K. Singh, Sheren X. Lin, and Victor C. Yang, "Serological Association of Measles Virus and Human Herpesvirus-6 with Brain Autoantibodies in Autism," Clinical Immunology and Immunopathology, Oct 1998, Vol. 89, No. 1, p 105-108.

Vaccines and Hearing Loss:

Orlando MP, Masieri S, Pascarella MA, Ciofalo A. Filiaci F, et al, "Sudden hearing loss Consequent to Hepatitis B Vaccination: a case report." Annals of the New York Academy of Sciences. 1997 Dec 29, 830: 319-321 Biacabe B, Erminy M, Bonfils P, et al, "A Case of Fluctuant Sensorineural Hearing Loss consequent to Hepatitis B Vaccination: a case report." Auris Nasus Larynx. 1997 Oct; 24(4): 357-360.

Watson JG, et al, "A Child of 3 years who developed an Encephalitic Reaction to MMR immunization at age 15 months." Int J Pediatr Otorhinolaryngol. 1990; 19:189-190. Mair IW, Elverland HH, et al, "Sudden deafness and vaccination." J Laryngol Otol. 1977 Apr; 91(4): 323-329. Stewart, B.J.A., et al. "Reports of sensorineural deafness after measles, mumps, and rubella immunisation." Archives of Diseases of Childhood 1993; 69:15354. Wirth G, et al. "Reversible Kochlearisschadigung nach Tetanol-Injektion?" Munch med Wschr. 1965 Aug; 107: 379-381. (Linking Tetanus toxoid in DTaP to hearing loss) Freed GL, Katz SL, Clark, SJ, et al. "Safety of vaccinations: Miss America, the media, and public health." JAMA. 1996; 276: 1869-1872. Eavey RD, et al. "Vaccine safety, media reporting, and Miss America." JAMA. 1997; Jul 23-30; 278(4): 290-291. Kaga, "Unilateral Total Loss of Auditory and Vestibular Function as a Complication of Mumps Vaccination", Int J Ped Oto, Feb 1998, 43(1):73-73 Nabe-Nielsen, Walter, "Unilateral Total Deafness as a Complication of the Measles- Mumps- Rubella Vaccination", Scan Audio Suppl, 1988, 30:69-70 Hulbert, et al, "Bilateral Hearing Loss after Measles and Rubella Vaccination in an Adult", NEJM, 1991 July, 11;325(2):134 Healy, "Mumps Vaccine and Nerve Deafness", Am J Disorder Child, 1972 Jun; 123(6):612 Jayarajan, Sedler, "Hearing Loss Following Measles Vaccination", J Infect, 1995 Mar; 30(2):184-185 Pialoux, P et al, "Vaccinations and Deafness", Ann Otolaryng (Paris), Dec 1963, 80:1012-1013. Angerstein, W, et al, "Solitary Hearing and Equilibrium Damage After Vaccinations", Gesundheitswesen, May 1995, 57(5): 264-268. Brodsky, Stanievich, "Sensorineural Hearing Loss Following Live Measles Virus Vaccination", Int J Ped Oto, 1985 Nov; 10(2):159-163 Koga, et al, "Bilateral Acute Profound Deafness After MMR Vaccination- Report of a Case", Nippon Jibiin Gakkai Kai, 1991 Aug;94(8):1142-5 Seiferth, LB, "Deafness after Oral Poliomyelitis Vaccination - a Case Report and Review", HNO, 1977 Aug; 25(8): 297-300 Pantazopoulos, PE, "Perceptive Deafness Following Prophylactic use of Tetanus anittoxin", Laryngoscope, Dec 1965, 75:1832-1836. Zimmerman, W, "Observation of a case of Acute Bilateral Hearing Impairment Following Preventive Poliomyelitis Vaccination (type 3)", Arch Ohr Nas Kehlkopfheilk, 1965, 185:723-725. Vaccines and Vision Loss:

Albitar S, et al. Bilateral retrobulbar optic neuritis with hepatitis B vaccination. Nephrol Dial Transplant. 1997 Oct;12(10):2169-70. Achiron LR, et al. Postinfectious hepatitis B optic neuritis. Optom Vis Sci 1994;71:53-6. Arya SC., et al. Ophthalmic complications of vaccines against hepatitis B virus. Int Ophthalmol. 1997;21(3):177-8. Baglivo E, et al. Multiple evanescent white dot syndrome after hepatitis B vaccine. Am J Ophthalmol. 1996 Sep;122(3):431-2. Berkman N, Benzarti T, Dhaoui R, Mouly P., et al. [Bilateral neuro-papillitis after hepatitis B vaccination] Presse Med. 1996 Sep 28;25(28):1301. French. Berkman N. [A case of segmentary unilateral occlusion of the central retinal vein following hepatitis B vaccination]. Presse Med. 1997 Apr 26;26(14):670. French. Bienfang DC, et al. Ocular abnormalities after influenza immunization. Arch Ophthalmol. 1977 Sep;95(9):1649. Bourges JL, Pisella PJ, Laurens C, Limon S. [Multifocal placoid epitheliopathy and anti-hepatitis B vaccination] J Fr Ophtalmol. 1998 Nov;21(9):696-700. French. Brezin A, et al. Visual loss and eosinophilia after recombinant hepatitis B vaccine. Lancet. 1993 Aug 28;342(8870):563-4. Brezin AP, Massin-Korobelnik P, Boudin M, Gaudric A, LeHoang P., et al. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch Ophthalmol. 1995 Mar;113(3):297-300.

Fong KS, et al. Multiple evanescent white dot syndrome--an uncommon cause for an enlarged blind spot. Ann Acad Med Singapore. 1996 Nov;25(6):866-8. Galli M, Morelli R, Casellato A, et al. Retrobulbar optic neuritis in a patient with acute type B hepatitis. Neurol Sci 1986;72:195-200. Granel B, et al. [Occlusion of the central retinal vein after vaccination against viral hepatitis B with recombinant vaccines. 4 cases]. Presse Med. 1997 Feb 1;26(2):62-5. French. Hull TP, et al. Optic neuritis after influenza vaccination. Am J Ophthalmol. 1997 Nov;124(5):703-4. Helies P, et al. [Oculo-palpebral complication of vaccination. Review of the literature]. J Fr Ophtalmol. 1994;17(1):62-6. Review. French. Kazarian EL, et al. Optic neuritis complicating measles, mumps, and rubella vaccination. Am J Ophthalmol. 1978 Oct;86(4):544-7. Kawasaki A, et al. Bilateral anterior ischemic optic neuropathy following influenza vaccination. J Neuroophthalmol. 1998 Mar;18(1):56-9. Kline L, Margulies SL, Oh SJ. Optic neuritis and myelitis following rubella vaccination. Arch Neurol 1982;39:443-4. Milkowski S. [Ocular complications following influenza]. Wiad Lek. 1971 Jan 15;24(2):103-8. Polish. McKibbin M, et al. Bilateral optic neuritis after hepatitis A. J Neurol Neurosurg Psychiatry. 1995 Apr;58(4):508. Ray CL, et al. Bilateral optic neuropathy associated with influenza vaccination. J Neuroophthalmol. 1996 Sep;16(3):182-4. Voigt U, Baum U, Behrendt W, Hegemann S, Terborg C, Strobel J. [Neuritis of the optic nerve after vaccinations against hepatitis A, hepatitis B and yellow fever] Klin Monatsbl Augenheilkd. 2001 Oct;218(10):688-90. German. Schuil J, van de Putte EM, Zwaan CM, Koole FD, Meire FM. Retinopathy following measles, mumps, and rubella vaccination in an immuno-incompetent girl.Int Ophthalmol. 1998;22(6):345-7. Solomon A, et al. Bilateral simultaneous corneal graft rejection after influenza vaccination. Am J Ophthalmol. 1996 Jun;121(6):708-9. Solomon A, et al. Adverse ocular effects following influenza vaccination. Eye. 1999 Jun;13 (Pt 3A):381-2. Stevenson VL, et al. Optic neuritis following measles/rubella vaccination in two 13-year-old children. Br J Ophthalmol. 1996 Dec;80(12):1110-1. Kawasaki A, et al. Bilateral anterior ischemic optic neuropathy following influenza vaccination. J Neuroophthalmol. 1998 Mar;18(1):56-9.

Vaccines and Autoimmunity:

Romanov, V A, et al, "Role of Auto-immune Processes in the Pathogenesis of Post-Vaccinal Lesions of the Nervous System", Oct 1977, Zh Mikrobiol Epidemiol Immunobiol, 10:80-83. Grachev, V P, et al, "Formation of Auto-antibodies in Laboratory Animals After Inoculation of Viruses With Different Virulence. I. Results of Studies ..., July 1973, Acta Virol (Praha), 17:319-326. Movsesiants, AA, et al, "Experimental Study of the Ability of Different Strains of Vaccinia Virus to Induce Auto-Antibody Formation", Vopr Virusol, May-Jun 1975; (3):297-302. Negina, IuP, "Comparative Study of Auto-antibody Formation Following Immunization With Different Types of Typhoid Vaccines", Zh Mikrobiol Epidemiol Immunobiol, May 1980; (5):69-72.

Vaccines and Autism:

Eggers, C, "Autistic Syndrome (Kanner) And Vaccinations against Smallpox", Klin Paediatr, Mar 1976, 188(2):172-180. Kiln MR, "Autism, inflammatory bowel disease, and MMR vaccine." Lancet 1998 May 2;351(9112):1358. Selway, "MMR vaccination and autism 1998. Medical practitioners need to give more than reassurance." BMJ 1998 Jun 13;316(7147):1824. Nicoll A, Elliman D, Ross E, "MMR vaccination and autism 1998," MJ 1998 Mar 7;316(7133):715-716.

Lindley K J, Milla PJ, "Autism, inflammatory bowel disease, and MMR vaccine."Lancet 1998 Mar 21;351(9106):907-908. Bedford H, et al, "Autism, inflammatory bowel disease, and MMR vaccine." Lancet 1998 Mar 21;351(9106):907. Vijendra K. Singh, Sheren X. Lin, and Victor C. Yang, "Serological Association of Measles Virus and Human Herpesvirus-6 with Brain Autoantibodies in Autism," Clinical Immunology and Immunopathology, Oct 1998, Vol. 89, No. 1, p 105-108. ["None of the autistic children in the study had measles in the past, but all had the MMR" stated David Whalgren.

The Hepatitis B Vaccine and Vision Loss:

Albitar S, et al. Bilateral retrobulbar optic neuritis with hepatitis B vaccination. Nephrol Dial Transplant. 1997 Oct;12(10):2169-70. Achiron LR, et al. Postinfectious hepatitis B optic neuritis. Optom Vis Sci 1994;71:53-6. Arya SC., et al. Ophthalmic complications of vaccines against hepatitis B virus. Int Ophthalmol. 1997;21(3):177-8. Baglivo E, et al. Multiple evanescent white dot syndrome after hepatitis B vaccine. Am J Ophthalmol. 1996 Sep;122(3):431-2. Berkman N, Benzarti T, Dhaoui R, Mouly P., et al. [Bilateral neuro-papillitis after hepatitis B vaccination] Presse Med. 1996 Sep 28;25(28):1301. French. Berkman N. [A case of segmentary unilateral occlusion of the central retinal vein following hepatitis B vaccination]. Presse Med. 1997 Apr 26;26(14):670. French. Bourges JL, Pisella PJ, Laurens C, Limon S. [Multifocal placoid epitheliopathy and anti-hepatitis B vaccination] J Fr Ophtalmol. 1998 Nov;21(9):696-700. French. Brezin A, et al. Visual loss and eosinophilia after recombinant hepatitis B vaccine. Lancet. 1993 Aug 28;342(8870):563-4. Brezin AP, Massin-Korobelnik P, Boudin M, Gaudric A, LeHoang P., et al. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch Ophthalmol. 1995 Mar;113(3):297-300. Galli M, Morelli R, Casellato A, et al. Retrobulbar optic neuritis in a patient with acute type B hepatitis. Neurol Sci 1986;72:195-200. Granel B, et al. [Occlusion of the central retinal vein after vaccination against viral hepatitis B with recombinant vaccines. 4 cases]. Presse Med. 1997 Feb 1;26(2):62-5. French. McKibbin M, et al. Bilateral optic neuritis after hepatitis A. J Neurol Neurosurg Psychiatry. 1995 Apr;58(4):508. Voigt U, Baum U, Behrendt W, Hegemann S, Terborg C, Strobel J. [Neuritis of the optic nerve after vaccinations against hepatitis A, hepatitis B and yellow fever] Klin Monatsbl Augenheilkd. 2001 Oct;218(10):688-90. German. The Hepatitis B Vaccine and Hearing Loss:

Orlando MP, Masieri S, Pascarella MA, Ciofalo A. Filiaci F, et al, "Sudden hearing loss Consequent to Hepatitis B Vaccination: a case report." Annals of the New York Academy of Sciences. 1997 Dec 29, 830: 319-321 Biacabe B, Erminy M, Bonfils P, et al, "A Case of Fluctuant Sensorineural Hearing Loss consequent to Hepatitis B Vaccination: a case report." Auris Nasus Larynx. 1997 Oct; 24(4): 357-360. The Hepatitis B Vaccine and Assorted Ailments:

Herroelen L. de Keyser J. Ebinger G. Central nervous system demyelination after immunization with recombinant hepatitis B vaccine. Lancet, 1991 Nov 9; 338 (8776):1174-75. Ribera ER. Dutka AJ. Polyneuropathy associated with administration of hepatitis B vaccine. N Engl J Med. 1983 Sep 8;309(10):614-5. Snider GB. Gogate SA. A possible systemic reaction to hepatitis B vaccine. JAMA 1985 Mar 1;253(9):1260-1. Fried M. Conen D. Conzelmann M. Steinemann E. Uveitis after hepatitis B vaccination. Lancet, 1987 Sep 12;2(8559:631-2. Shaw FE Jr. Graham DJ. Guess HA, et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. Am J Epidemiol 1988 Feb;127(s):337-52. Biron P. Montpetit P. Infante-Rivard C. Lery L. Myasthenia gravis after general anesthesia and hepatitis B vaccine. Arch Intern Med. 1988 Dec;148(12):2685. Goolsby PL. Erythema nodosum after Recombivax HB hepatitis B vaccine. N Engl J Med 1989 Oct;321:1198-9. Anonymous, hepatitis B vaccines: reported reactions. World Health Organization Adverse Drug Reaction Bulletin. August 1990. Cockwell P. Allen MB. Page R. Vasculitis related to hepatitis B vaccine. BMJ 1990 Dec 1;301(6763):1281. Tudela P. Marti S. Bonal J. Systemic lupus erthemoatosus and vaccination against hepatitis B. Nephron 1992 62(2):236. Ganry O. Lerailler F. Vercelleto M. Chiffoleau A. Larouse C. Peripheral facial paralysis following vaccination against hepatitis B. Apropos of a case. Therapie. 1992;47:437-438. Trevisani F. Gattinara GC. Caraceni P, et al. Transverse myelitis following hepatitis B vaccination. J Hepatol 1993 Sep;19(2):317-8. Mahassin F. Algayres JP. Valmary J, et al. Acute myelitis after vaccination against hepatitis B. Presse Med 1993 Dec 18;22(40):1997-8. Nadler JP. Multiple sclerosis and hepatitis B vaccination. Clin Infect Dis 1993 Nov:17(5):928-9. Brezin A. Lautier-Frau M. Hamedani M. Rogeaux O. Hoang PL. Visual loss and eosinophilia after recombinant hepatitis B vaccine. Lancet 1993 Aug 28;342(8870):563-4. Trevisian G. Stinco G. Lichen rubber planus following HBV vaccination. Acta Dermato-Venereologica 1993 Feb;73(1):73. Castresana-Isla CJ. Herrera-Martinez G. Vega-Molina J. Erythema nodosum and Takayasu's arteritis after immunization with plasma derived hepatitis B vaccine. J Rheumatol 1993 Aug;20(8):1417-8. Allen MB. Cockwell P. Page RL. Pulmonary and cutaneous vasculitis following hepatitis B vaccination. Thorax 1993 May;48(5):580-1. Deisenhammer F. Pohl P. Bosch S. Schmidauer C. Acute cerebellar ataxia after immunisation with recombinant hepatitis B vaccine. Acta Neurol Scand 1994 Jun;89(6):462-3. Vautier G. Carty JE. Acute sero-positive rheumatoid arthritis occurring after hepatitis vaccination. Br J Rheumatol 1994 Oct;33(10):991. Hassan W. Oldham R. Reiter's syndrome and reactive arthritis in health care workers after vaccination. BMJ 1994 Jul 9;309(6967):94. Aubin F. Angonin R. Humbert P. Agache P. Lichen planus following hepatitis B vaccination. Archives of Dermatology. 1994 Oct;130(10):1329-30. Birley HD. Arya OP. Hepatitis B immunisation and reactive arthritis. BMJ 1994 Dec;309(6967):1514. Poullin P. Gabriel B. Thrombocytopenic purpura after recombinant hepatitis B vaccine. Lancet 1994 Nov;344(8932):1293. Di Lernia V. Lo Scocco G. Bisighini G. Erythema multiforme following hepatitis B vaccine. Ped Derma 1994 Dec;11(4):363-4. Fraser PA. Wilson JD. Reiter's syndrome attributed to hepatitis B immunisation. BMJ 1994 Dec;309(6967):1513. Lilic D. Ghosh SK. Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lancet 1994 Nov;344(8932):1292-3. Brezin AP. Massin-Korobelnik P. Boudin B., et al. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch Ophthal 1995 Mar;113(3):297-300. Gross K. Combe C. Kruger K. Schattenkkirchner M. Arthritis after hepatitis B vaccination. Report of three cases. Scand J Rheumatol. 1995;24(1):50-2. Kaplanski G. Retornaz F. Durand J. Soubeyrand J. Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype. J Neurol Neurosurg Psychiatry 1995 Jun;58(6):758-9.

Tartaglino LM. Heiman-Patterson T. Friedman DP. Flanders AE. MR imaging in a case of postvaccination myelitis. AJNR Am J Neuroadiol 1995;16(3):581-2. Macario F. Freitas L. Correira J., et al. Nephrotic syndrome after recombinant hepatitis B vaccine. Clin Nephrol 1995 May;43(5):349. Germanaud J. Causse X. Trinh DH., et al. A case of severe cytolysis after hepatitis B vaccination. Amer J Med 1995 Jun;98(6):595-6. Meyboom RH. Fucik H. Edwards IR. Thrombocytopenia reported in association with hepatitis B and A vaccines. Lancet 1995 Jun;345(8965):1638. Aherne P. Collins M. Psoriatic arthropathy. Irish Medical Journal 1995 Mar-Apr;88(2):72. Guiserix J. Systemic lupus erythematosus following hepatitis B vaccine. Nephron 1996;74(2):441. Bonfils P. Biacabe B. Potard G. Aidan D. Fluctuant perception hearing loss after hepatitis B vaccine. Ann Otolaryngol Chir Cervicofac 1996;113(6):359-61. Baglivo E. Safran AB. Borruat FX. Multiple evanescent white dot syndrome after hepatitis B vaccine. Am J Ophthalmol 1996 Sep;122(3):431-2. Grezard P. Chefai M. Philipott V. Perrot H. Faisant M. Cutaneous lupus erythematosus and buccal aphthosis after hepatitis B vaccination in a 6-year old child. Ann Dermatol Venereol. 1996;123(10):657-9. Classen JB. The diabetes epidemic and the hepatitis B vaccines. New Zealand Med J. 1996 Sep;109(1030):366. Classen JB. Childhood immunisation and diabetes mellitus. New Zealand Med J 1996 May;109(1022):195. Manna R. De Santis A. Oliviero A., et al. Leukoencephalitis after recombinant hepatitis B vaccine. J Hepatol. 1996 June;24(6):764-5. Devin F. Roques G. Disdier P., et al. Occlusion of central retinal vein after hepatitis B vaccination. Lancet 1996 Jun;347(9015):1626. Cohen AD. Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmunity 1996 Dec;9(6):699-703. Mathieu E. Fain O. Krivitzky A. Cryoglobulinemia after hepatitis B vaccination. New England J Med 1996 Aug;335(5):335. Dauod MS. Dicken CH. Anetoderma after hepatitis B immunization in two siblings. J Amer Acad Dermo 1997 May;36(5 Pt 1): 779-80. Harrison BJ. Thomson W. Pepper L, et al. Patients who develop inflammatory polyarthritis (IP) after immunization are clinically indistinguishable from other patients with IP. Br J Rheumatol 1997 Mar;36(3):366-9. Wise RP. Kiminyo KP. Salive ME. Hair loss after routine immunizations. JAMA 1997 Oct 8;278(14):1176-8. Song HK. Kim HC. Yun YH. Acute Myelitis after hepatitis B vaccination. J Korean Med Sci 1997 Jun;12(3):249-51. Granel B. Disdier P. Devin F, et al. Occlusion of the central retinal vein after vaccination against viral hepatitis B with recombinant vaccines. 4 cases. Presse Med 1997 Feb 1;26(2):62-5. Saywell CA. Wittal RA. Kossard S. Lichenoid reaction to hepatitis B vaccination. Australasian J Derm 1997 Aug;38(3):152-4. Biacabe B. Erminy M. Bonfils P. A case report of fluctuant sensorineural hearing loss after hepatitis B vaccination. Auris, Nasus, Larynx 1997 Oct;24(4):35760. Arya SC. Ophthalmic complications of vaccines against hepatitis B virus. Int Ophth 1997;21(3):177-8. Bracci M. Zopinni A. Polyarthritis associated with hepatitis B vaccination. British J Rheumatol 1997 Feb;36(2):300-1. Maillefert JF. Farge P. Gazet-Maillefert MP. Tavernier C. Mental nerve neuropathy as a result of hepatitis B vaccination. Oral Surg Oral Med Orla Path Oral Radio & Endo 1997 Jun;83(6):663-4. Ranieri VM. Dell'Erba A. Gentile A., et al. Liver inflammation and acute respiratory distress syndrome in a patient receiving hepatitis B vaccine: a possible relationship?. Intensive Care Medicine 1997 Jan;23(1):119-21. Kakar A. Sethi PK. Guillain Barre syndrome associated with hepatitis B vaccination. Indian J Ped 1997 Sept-Oct;64(5):710-2. Orlando MP. Masieri S. Pascarella MA., et al. Sudden hearing loss in childhood consequent to hepatitis B vaccination: a case report. Annals of New York Academy of Sciences 1997 Dec;830:319-21. Pope JE. Stevens A. Howson W. Bell DA. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 1998 Sep;25(9):1687-93. Neau D. Bonnet F. Michaud M, et al. Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven case. Scan J.

Infect Dis 1998;30(2):115-8. Ronchi F. Cecchi P. Falcioni F, et al. Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine. Arch Dis Child 1998 Mar;78(3):273-4. Grasland A. Le Maitre F. Pouchot J, et al. Adult-onset Still's disease after hepatitis A and B vaccination? Rev Med Interne 1998 Feb;19(2):134-6. Finielz P. Lam-Kam-San LF. Guiserix J. Systemic lupus erythematosus and thrombocytopenic purpura in two members of the same family following hepatitis B vaccine. Nephrol Dial Transplant 1998;13(9):2420-1. Le Hello C. Cohen P. Bousser MG. Letellier P. Guillevin L: Suspected hepatitis B vaccination related vasculitis. J Rheumatol, 1999 Jan;26(1):191-4. Renard JL. Guillamo JS. Ramirez JM, et al. Acute transverse cervical myelitis following hepatitis B vaccination. Evolution of anti-HBs antibodies. Presse Med 1999 Jul 3-10;28(24):1290-2. Tourbah A. Gout O. Liblau R. Lyon-Caen O, et al. Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS? Neurology 1999 Jul 22;53(2):396-401. De Keyser F. Naeyaert JM. Hindryckx P, et al. Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol 2000 Jan-Feb;18(1):81-5. Konstantinou D. Paschalis C. Maraziotis T, et al. Two episodes of leukoencephalites associated with recombinant hepatitis B vaccination in a single patient. Clin Inf Dis 2001 Nov 15;33:1772-3. Creange A. Temam G. Lefaucher JP. Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination. Autoimmunity 1999;30:143-6. Usman A. Kimyai-Asadi A. Stiller MJ. Alam M. Lichenoid eruption following hepatitis B vaccination: first North American case report. Pediatr Dermatol. 2001 Mar-Apr;18(2):123-6. Conesa V. Nunez MF. Navarro JF. Mompel A. Ruiz J. Gomez A. Thrombocytopenic Purpura after Recombinant Hepatitis B Vaccine. A rare association. Haematologica. 2001 Mar;86(3):E09 Zaas A. Scheel P. Venbrux A. Helmann DB. Large artery vasculitis following recombinant hepatitis B vaccination. 2 cases. J Rheumatol. 2001 May;28(5):111620. Al-Khenaizan S. Lichen planus occurring after hepatitis B vaccination: a new case. J Am Acad Dermatol. 2001 Oct;45(4):614-5. Barbaud A. Trechot P. Reichert-Penetrat S. Weber M. Schmutz JL. Allergic mechanisms and urticaria/angioedema after hepatitis B immunization. Br J Dermatol. 1998 Nov;139(5):925-6. Ferrando MF. Doutre MS. Beylot-Barry M. Durand I. Beylot C. Lichen planus following hepatitis B vaccination. Br J Dermatol. 1998 Aug;139(2):350. Rabaud C. Barbaud A. Trechot P. First case of erythermalgia related to hepatitis B vaccination. Journal of Rheumatol. 26(1):233-4, 1999 Jan. Schupp P. Vente C. Lichen planus following hepatitis B vaccination. International Journal of Dermatol. 38(10):799-800, 1999 Oct. Maillefert JF. Sibilia J. Toussirot E., et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatol (Oxford). 1999 Oct;38(10):978-83. Fledelius HC. Unilateral papilloedema after hepatitis B vaccination in a migraine patient. A case report including forensic aspects. Acta Ophthalmol Scand. 1999 Dec;77(6):722-4. Muller A. Kertzscher F. Kiefel V. Lenk H. Thrombocytopenic purpura: adverse reaction to a combined immunisation (recombinant hepatitis B and measlesmumps-rubella-vaccine) and after therapy with Co-trimoxazole. Eur J Pediatr. 1999 Dec;158 Suppl 3:S209-10. Stewart O. Chang B. Bradbury J. Simultaneous administration of hepatitis B and polio vaccines associated with bilateral optic neuritis. Br J Ophthalmol. 1999 Oct;83(10):1200-1. Islek I. Cengiz K. Cakir M. Kucukoduk S. Nephrotic syndrome following hepatitis B vaccination. Pediatr Nephrol. 2000 Jan;14(1):89-90. Loche F. Schwarze HP. Thedenat B. Carriere M. Bazex J. Erythema multiforme associated with hepatitis B immunization. Clin Exp Dermatol. 2000 Mar;25(2):167-8. Viallard JF. Boiron JM. Parrens M. Moreau JF. Ranchin V. Reiffers J. Leng B. Pellegrin JL. Severe pancytopenia triggered by recombinant hepatitis B vaccine.

Br J Haematol. 2000 Jul;110(1):230-3. Toussirot E. Lohse A. Wendling D. Mougin C. Sjogren's syndrome occurring after hepatitis B vaccination. Arthritis Rheumatol. 2000 Sep;43(9):2139-40. Sinsawaiwong S. Thampanitchawong P. Guillain-Barre syndrome following recombinant hepatitis B vaccine and literature review. J Med Assoc Thai. 2000 Sep;83(9):1124-6. Agrawal S. Garg VK. Joshi A. Agarwalla A. Sah SP. Lichen planus after HBV vaccination in a child: a case report from Nepal. J Dermatol. 2000 Sep;27(9):61820. Flemmer M. Oldfield EC 3rd. The bald truth. Am J Gastroenterol. 1999 Apr;94(4):1104. Gran B. Bielekova B. McFarland HF. Martin R. Development of Multiple Sclerosis after hepatitis B vaccination. Neurol 2000;54(suppl 3):A164. Biasi D. Carletto A. Caramaschi P. Frigo A. Pacor M. Bezzi D., et al. Rheumatological manisfestations following hepatitis B vaccination. Report of three cases. Scand J Rheumatol. 1995;24:50-52. Rogerston SJ. Nye FJ. Hepatitis B vaccine associated with erythema nodosum and poly arthritis. BMJ. 1990;301:345. Wieland KK. Cohen MR. Hepatitis B vaccine: Recombivax reaction. Nursing. 88;18:87. Mamoux V. Dumont C. Lupus erthymatosus disseminatus and vaccination against hepatitis B virus. Arch Pediatr. 1994;1:307-309. Martinez E. Domingo P. Evan's syndrome triggered by recombinant hepatitis B vaccine. Clin Infect Dis. 1992;15:1051. AADRAC. Australian Adverse Drug Reactions Advisory Committee: Reactions to hepatitis B vaccines. Austr Adv Drug React Bull;1990. Nagafuchi S. Tokiyam K. Kashiwagi S. Yayashi S. Imayama S. Niho Y. Eosinophillia after intradermal hepatitis B vaccination. Lancet. 1993;342:998.

Vaccines, Leukemia and Lymphomas:

Bichel, "Post-vaccinial Lymphadenitis Developing into Hodgkins Disease", Acta Med Scand, 1976, Vol 199, p523-525. Stewart, AM, et al, "Aetiology of Childhood Leukaemia", Lancet, 16 Oct, 1965, 2:789-790. Glathe, H et al, "Evidence of Tumorigenic Activity of Candidate Cell Substrate in Vaccine Production by the Use of Anti-Lymphocyte Serum", Development Biol Std, 1977, 34:145-148. Bolognesi, DP, "Potential Leukemia Virus Subunit Vaccines: Discussion", Can Research, Feb 1976, 36(2 pt 2):655-656. Colon, VF, et al, "Vaccinia Necrosum as a Clue to Lymphatic Lymphoma", Geriatrics, Dec 1968, 23:81-82. Park-Dincsoy, H et al, "Lymphoid Depletion in a case of Vaccinia Gangrenosa", Laval Med, Jan 1968, 39:24-26. Hugoson, G et al, "The Occurrence of Bovine Leukosis Following the Introduction of Babesiosis Vaccination", Bibl Haemat, 1968, 30:157-161. Hartstock, , ""Post-vaccinial Lymphadenitis: Hyperplasia of Lymphoid Tissue That Simulates Malignant Lymphomas", Apr 1968, Cancer, 21(4):632-649. Allerberger, F, "An Outbreak of Suppurative Lymphadenitis Connected with BCG Vaccination in Austria- 1990/1991," Am Rev Respir Disorder, Aug 1991, 144(2) 469. Omokoku B, Castells S, "Post-DPT inoculation cervical lymphadenitis in children." N Y State J Med 1981 Oct;81(11):1667-1668.

Vaccines and Chromosome Changes Leading to Mutations:

Knuutila, S et al, "An Increased Frequency of Chromosomal Changes and SCEs in Cultured Lymphocytes of 12 Subjects Vaccinated Against Smallpox," Hum Genet, 1978 Feb 23; 41(1):89-96.

Cherkeziia, SE, et al, "Disorders in the Murine Chromosome Apparatus Induced By Immunization with a Complex of Anti-viral Vaccines," Vopr Virusol, 1979 Sept Oct, (5):547-550. [SCE means sister chromatid exchange and is an indication that genetic mutations are occurring, which could possibly lead to cancercausing mutations.]

The Polio Vaccine Has Been Linked to Cancer: uman exposure to SV40." American Journal of Epidemiology, 1976; 103: 1-12. Nature, 1968; 219:972-73. Nature, 1974; 249:421-24. ., et a;. "Simian virus 40-related antigens in three human meningiomas with defined chromosome loss." Proceedings of the National Academy of Science 1975; 72(2):609-13. -40-like papovavirus from a human glioblastoma." International Journal of Cancer 1979; 24:523-31. tigen and specific antibodies in patients with oromaxillofacial tumors." Virologie, 1987; 38:35-40. ti-SV40 antibodies in patients with parotid gland tumors." Virologie, 1987; 38:41-46. "Association between the occurrence of antibodies to simian vacuolating virus 40 and bladder cancer in male smokers." Neoplasma, 1988; 35:285-88. -antigen cause Kaposi's sarcoma-like tumors in nude mice." American Journal of Pathology, 1991; 139(4):74349. New England Journal of Medicine, 1972; 286:38590. . "Screening of human brain tumors for SV-40-related T-antigen." International Journal of Cancer 1978; 21:12-17. -related DNA sequences in a human brain tumor." Neurology 1979; 29:1590-94. Episomal simian virus 40 genomes in human brain tumors." Proceedings of the National Academy of Science 1981; 78:6446-50. Proceedings of the National Academy of Sciences of the USA, 1981, 78(10):6446-6450. Virology 1984; 138:336-40. -and-run' agent?" Z Klin Med, 1986; 41:493-95. Progress in Medical Virology, 1990; 37:211-222. ldhood." New England Journal of Medicine, 1992; 326:988-93. Journal of the National Cancer Institute, 1995, 87(17):1331. dymoma Tumors." Virology, 1995, 212(2):710-17. -40, and Nonrandom Chromosome Changes in Two Gioblastoma Cell Lines." Cancer Genetics and Cytogenics, 1996, 90(1): 17-23. -40 Like Sequences in Human Bone Tumors." Oncogene, 1996, 13(3):527-35. -40 Like Sequences in Human Mesotheliomas." Important Advances in Oncology, 1996, pp. 89-108. Money, (December 1996), p. 161. [Article] San Francisco Chronicle (July 15, 2001), p. 7. [Article: Research by Susan Fisher, epidemiologist, Loyola University Medical Center.]

The Boston Globe (January 26, 1997). [Article] -poliovirus vaccine of mothers offspring with neurological tumors." New England Journal of Medicine, 1988; 318:1469. Response to: "Neurological tumors in offspring after inoculation of mothers with killed poliovirus vaccine." New England Journal of Medicine, 1988, 319:1226. Autism and the MMR (or Measles) Vaccine:

-40 Early Region and Large T Antigen in Human Brain Tumors, Peripheral Blood Cells, and Sperm Fluids from Healthy Individuals." Cancer Research, 1996, 56(20):4820-4825. Oleske, J. "Elevated rubeola [measles] titers in autistic children." Abstract presented by D. Zecca and Dr. Graffino at an NIH meeting (September 23, 1997). As quoted by Richard Gallup in "Autism and autoimmunity." www.chiroweb.com/archives/18/14/10.html April 15, 2002. Fudenberg, H.H. "Dialysable lymphocyte extract (DlyE) in infantile onset autism: a pilot study." Biotherapy 1996; 9:143-147. Gupta, S. "Immunology and immunologic treatment of autism." Proceedings of the National Autism Association, Chicago 1996: 455-460. Wakefield, A.J., et al. "Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children." Lancet 1998; 351:637-641. Yazbak, F.E. "Autism: Is there a vaccine connection? Part I. Vaccination after delivery." 1999. Part I Yazbak, F.E. "Autism: Is there a vaccine connection? Part II. Vaccination around pregnancy." 1999. Part II Yazbak, F.E. "Autism: Is there a vaccine connection? Part III. Vaccination around pregnancy, the sequel." 2000. Part III "Autism: Present Challenges, Future Needs -- Why the Increased Rates?" Government Reform Committee Hearing, Washington, DC. (April 6, 2000.) Bernard, S., et al. "Autism: a novel form of mercury poisoning," (July 2000). Submitted to the Government Reform Committee Hearing, Washington, DC. (July 18, 2000.) www.house.gov/reform/healthcare/mercury_paper.htm "Autism: Why the Increased Rates? A One-Year Update." Government Reform Committee Hearing, Washington, DC. (April 25-26, 2001.) "The Autism Epidemic: Is the NIH and CDC Response Adequate?" Government Reform Committee Hearing, Washington, DC. (April 18, 2002.) "The Status of Research into Vaccine Safety and Autism." Government Reform Committee Hearing, Washington, DC. (June 19, 2002.) Kawashima, K., et al. "Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism." Digestive Diseases and Sciences (April 2000); 45:723-729. Reuters Medical News. "Measles persistence confirmed in some patients with IBD, autistic enterocolitis." (June 20, 2000). www.id.medscape.com/reuters/prof/2000/ 06/06.20/20000620scie001.html Wakefield, A.J. et al. "Enterocolitis in children with developmental disorders." American Journal of Gastroenterology 2000; 95(9):2154-2156. Wakefield, A., et al. "Measles, mumps and rubella vaccine: through a glass, darkly." Adverse Drug Reaction and Toxicologica Reviews 2000; 19(4):265-283. Kiln MR, "Autism, inflammatory bowel disease, and MMR vaccine." Lancet 1998 May 2;351(9112):1358. Selway, "MMR vaccination and autism 1998. Medical practitioners need to give more than reassurance." BMJ 1998 Jun 13;316(7147):1824. Nicoll A, Elliman D, Ross E, "MMR vaccination and autism 1998," MJ 1998 Mar 7;316(7133):715-716. Lindley K J, Milla PJ, "Autism, inflammatory bowel disease, and MMR vaccine."Lancet 1998 Mar 21;351(9106):907-908. Bedford H, et al, "Autism, inflammatory bowel disease, and MMR vaccine." Lancet 1998 Mar 21;351(9106):907. Vijendra K. Singh, Sheren X. Lin, and Victor C. Yang, "Serological Association of Measles Virus and Human Herpesvirus-6 with Brain Autoantibodies in Autism," Clinical Immunology and Immunopathology, Oct 1998, Vol. 89, No. 1, p 105-108. Peltola, et al. "No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study." Lancet 1998;

351:1327-1328. Taylor, et al. "Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association." Lancet 1999; 353:2026-2029. Eggers, C, "Autistic Syndrome (Kanner) and Vaccinations against Smallpox", Klin Paediatr, Mar 1976, 188(2):172-180.

Essex, M., et al. "The origin of the AIDS virus." Scientific American, 1988; 259:64-71. Karpas, A. "Origin and Spread of AIDS." Nature, 1990; 348:578. Kyle, Walter S. "Simian retroviruses, poliovaccine, and origin of AIDS." Lancet, 1992; 339:600-601. Elswood, B.F. and Stricker, R.B. "Polio vaccines and the origin of AIDS." Medical Hypothesis, vol. 42, 1994, pp. 347-354. Myers, G., et al. "The emergence of simian/human immunodeficiency viruses." AIDS Res Human Retro 1992: 8:373-86. Workshop on Simian Virus-40 (SV-40): A Possible Human Polyomavirus. (National Vaccine Information Center, January 27-28, 1997.) www.909shot.com/polio197.htm (Includes a summary of evidence presented at the Eighth Annual Houston Conference on AIDS.) Martin, Brian. "Polio vaccines and the origin of AIDS: The career of a threatening idea." Townsend Letter for Doctors (January 1994), pp. 97-100. Curtis, Tom. "Did a polio vaccine experiment unleash AIDS in Africa?" The Washington Post (April 5, 1992), pp. C3+. World Health Organization. "T-lymphotropic retroviruses of nonhuman primates." WHO informal meeting. Weekly Epidemiology Records, 1985; 30:269-70. Huet, T., et al. "Genetic organization of a chimpanzee lentivirus related to HIV-1." Nature 1990; 345:356-359. Desrosiers, R.C. "HIV-1 origins: A finger on the missing link." Nature 1990; 345:288-89. Sabin, A.B. "Properties and behavior of orally administered attenuated poliovirus vaccine." Journal of the American Medical Association 1957; 164: 1216-23. Plotkin, S.A., Koprowski, H., et al. "Clinical trials in infants of orally administered poliomyelitis viruses." Pediatrics 1959; 23:1041-62. Barin, F., et al. "Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of West Africa." Lancet 1985; ii:1387-1389. Hirsch, V.M., et al. "Simian immunodeficiency virus infection of macaques: End-stage disease is characterized by widespread distribution of proviral DNA in tissues." Journal of Infectious Disease 1991; 163:976-988. Bohannon, R.C., et al. "Isolation of a Type D retrovirus from B-cell lymphomas of a patient with AIDS." Journal of Virology 1991; 65(11):5663-72. Khabbaz, R.F., et al. "Simian immunodeficiency virus needlestick accident in a laboratory worker." Lancet 1992; 340:271-73. Gao, F., et al. "Human infection by genetically diverse SIVsm-related HIV-2 in West Africa." Nature 1992; 358:495-99. Giunta S., et al. "The primate trade and the origin of AIDS viruses." Nature 1987; 329:22. Seale, J. "Crossing the species barrier -- viruses and the origins of AIDS in perspective." J R Soc Med 1989; 82:519-23. Lecatsas G. "Origin of AIDS." Nature 1991; 351:179. Koprowski, H. "Historical aspects of the development of live virus vaccine in poliomyelitis." British Medical Journal 1960; ii:85-91. Lebrun, A., et al. "Vaccination with the CHAT strain of Type 1 attenuated poliomyelitis virus in Leopoldville, Belgian Congo." Bulletin of the World Health Organization 1960; 22:203-213. Sabin, A.B. "Present position of immunization against poliomyelitis with live virus vaccines." British Medical Journal 1959; i:663-680. Mahmias, A.J., et al. "Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959." Lancet 1986; i:1279-80. Huminer, D., et al. "AIDS in the pre-AIDS era." Rev Infect Dis 1987; 9:1102-08. Corbitt, G., et al. "HIV infection in Manchester, 1959." Lancet 1990; ii:51. Cohen, J. "Debate on AIDS origin: Rolling Stone weighs in -- Controversial article angers vaccine experts by claiming AIDS could have been spread by polio vaccines in Africa." Science (March 1992), p. 1505. [Article]

Sonnet, J., et al. "Early AIDS cases originating from Zaire and Burtundi (1962-1976)." Scandinavian Journal of Infectious Disease 1987; 19:511-17.

Vaccines and Unexplained Diseases:

Hiner, E E, Frasch, C E, "Spectrum of Disease Due to Haemophilus Influenza Type B Occurring in Vaccinated Children", J Infect Disorder, 1988 Aug; 158(2): 343-348. Olin P, Romanus, V, Storsaeter, J, "Invasive Bacterial Infections During an Efficiacy Trial of Acellular Pertussis Vaccines --Implications For Future Surveilance In Pertussis Vaccine Programmes", Tokai J Exp Clin Med, 1988; 13 Suppl: 143-144. Storsaeter, J, et al, "Mortality and Morbidity From Invasive Bacterial Infections During a Clinical Trial of Acellular Pertussis Vaccines in Sweden", Pediatr Infect Disorder J, 1988 Sept; 7(9):637-645. Vadheim, CM, et al, "Effectiveness and Safety of an Haemophilus Influenzae type b Conjugate Vaccine (PRP-T) in Young Infants. Kaiser-UCLA Vaccine Study Group," Pediartics, 1993 Aug; 92(2):272-279. [The vaccines caused fevers, irritability, crying, and seizures, but were declared to be "safe and ... effective ... ".] Stickl, H, "Estimation of Vaccination Damage", Med Welt, Oct 14, 1972, 23:1495-1497. Waters, VV, et al, "Risk Factors for Measles in a Vaccinated Population", JAMA, Mar 27, 1991, 265(12): 1527. Stickl, H, "Iatrogenic Immuno-suppression as a Result of Vaccination", Fortschr Med, Mar 5, 1981, 99(9);289-292.

Vaccines Cause the "Prevented" Disease:

Nkowane, et al, "Vaccine-Associated Paralytic Poliomyelitis, US 1973 through 1984, JAMA, 1987, Vol 257:1335-1340. Quast, et al, "Vaccine Induced Mumps-like Diseases", nd, Int Symp on Immun, Development Bio Stand, Vol 43, p269-272. Green, C et al, "A Case of Hepatitis Related to Etretinate Therapy and Hepatitis B Vaccine", Dermatologica, 1991, 182(2):119-120. Shasby, DM, et al, "Epidemic Measles in Highly Vaccinated Population", NEJM, Mar 1977, 296(11): 585-589. Tesovic, G et al, "Aseptic Meningitis after Measles, Mumps and Rubella Vaccine", Lancet, Jun 12, 1993, 341(8859):1541. Johnson, RH, et al, "Nosocomial Vaccinia Infection", West J Med, Oct 1976, 125(4):266-270. Malengreau, M, "Reappearance of Post-Vaccination Infection of Measles, Rubella, and Mumps. Should Adolescents be re-vaccinated?" Pedaitric, 1992;47(9):597-601 (25 ref) Basa, SN, "Paralytic Poliomyelitis Following Inoculation With Combined DTP Prophylactic. A review of Sixteen cases with Special Reference to Immunization Schedules in Infancy", J Indian Med Assoc, Feb 1, 1973, 60:97-99. Landrigan, PJ et al, "Measles in Previously Vaccinated Children in Illinois", Ill Med J, Arp 1974, 141:367-372. NA, "Vaccine-Associated Poliomyelitis", Med J Aust, Oct 1973, 2:795-796.

Vaccine Failures:

Hardy, GE, Jr, et al, "The Failure of a School Immunization Campaign to Terminate an Urban Epidemic of Measles," Amer J Epidem, Mar 1970; 91:286-293. Cherry, JD, et al, "A Clinical and Serologic Study of 103 Children With Measles Vaccine Failure", J Pediatr, May 1973; 82:801-808. Jilg, W, et al, "Inoculation Failure Following Hepatitis B Vaccination", Dtsch Med wochenschr, 1990 Oct 12; 115(41):1514-1548. Plotkin, SA, "Failures of Protection by Measles Vaccine," J Pediatr, May 1973; 82:798-801.

Bolotovskii, V, et al, "Measles Incidence Among Children Properly Vaccinated Against This Infection", ZH Mikrobiol Epidemiol Immunobiol, 1974; 00(5):3235. Landrigan, PJ, et al, "Measles in Previously Vaccinated Children in Illinois", Ill Med J, Apr 1974; 141:367-372. Strebel, P et al, "An Outbreak of Whooping Cough in a Highly Vaccinated Urban Community", J Trop Pediatr, Mar 1991, 37(2): 71-76. Forrest, JM, et al, "Failure of Rubella Vaccination to Prevent Congenital Rubella,"Med J Aust, 1977 Jan 15; 1(3): 77. Jilg, W, "Unsuccessful Vaccination against Hepatitis B", Dtsch Med Wochenschr, Nov 16, 1990, 115(46):1773. Coles, FB, et al, "An Outbreak of Influenza A (H3N2) in a Well-Immunized Nursing home Population," J Am ger Sociologist, Jun 1992, 40(6):589-592. Jilg, W, et al, "Inoculation Failure following Hepatitis B Vaccination," Dtsch Med Wochenschr, Oct 12, 1990, 115(41):1545-1548. Hartmann, G et al, "Unsuccessful Inoculation against Hepatitis B," Dtsch Med Wochenschr, May 17, 1991, 116(20): 797. Buddle, BM et al, "Contagious Ecthyma Virus-Vaccination Failures", Am J Vet Research, Feb 1984, 45(2):263-266. Mathias, R G, "Whooping Cough In Spite of Immunization", Can J Pub Health, 1978 Mar/Apr; 69(2):130-132. Osterholm, MT, et al, "Lack of Efficacy of Haemophilus b Polysacharide Vaccine in Minnesota", JAMA, 1988 Sept 9; 260(10:1423-1428. Johnson, RH, et al, "Nosocomial Vaccinia Infection", West J Med, Oct 1976, 125(4):266-270.

Vaccines Causing Another Vaccinal Disease:

Basa, SN, "Paralytic Poliomyelitis Following Inoculation With Combined DTP Prophylactic. A review of Sixteen cases with Special Reference to Immunization Schedules in Infancy", J Indian Med Assoc, Feb 1, 1973, 60:97-99. Pathel, JC, et al, "Tetanus Following Vaccination Against Small-pox", J Pediatr, Jul 1960; 27:251-263. Favez, G, "Tuberculous Superinfection Following a Smallpox Re-Vaccination", Praxis, July 21, 1960; 49:698-699. Quast, Ute, and Hennessen, "Vaccine-Induced Mumps-like Diseases", Intern Symp on Immunizations , Development Bio Stand, Vol 43, p 269-272. Forrest, J M, et al, "Clinical Rubella Eleven months after Vaccination," Lancet, Aug 26, 1972, 2:399-400. Dittman, S, "Atypical Measles after Vaccination", Beitr Hyg Epidemiol, 19891, 25:1-274 (939 ref) Sen S, et al, "Poliomyelitis in Vaccinated Children", Indian Pediatr, May 1989, 26(5): 423-429. Arya, SC, "Putative Failure of Recombinant DNA Hepatitis B Vaccines", Vaccine, Apr 1989, 7(2): 164-165. Lawrence, R et al, "The Risk of Zoster after Varicella Vaccination in Children with Leukemia", NEJM, Mar 3, 1988, 318(9): 543-548.

Vaccines and Death:

Na, "DPT Vaccination and Sudden Infant Death - Tennessee, US Dept HEW, MMWR Report, Mar 23, 1979, vol 28(11): 132. Arevalo, "Vaccinia Necrosum. Report on a Fatal Case", Bol Ofoc Sanit Panamer, Aug 1967, 63:106-110. Connolly, J H, Dick, G W, Field, CM, "A Case of Fatal Progressive Vaccinia", Brit Med Jour, 12 May 1962; 5288:1315-1317. Aragona, F, "Fatal Acute Adrenal Insufficiency Caused by Bilateral Apoplexy of the Adrenal Glands (WFS) following Anti-poliomyelitis Vaccination", Minerva Medicolegale, Aug 1960; 80:167-173. Moblus, G et al, "Pathological-Anatomical Findings in Cases of Death Following Poliomyelitis and DPT Vaccination", Dtsch Gesundheitsw, Jul 20, 1972, 27:1382-1386. NA, "Immunizations and Cot Deaths", Lancet, Sept 25, 1982, np. Goetzeler, A, "Fatal Encephalitis after Poliomyelitis Vaccination", 22 Jun 1961, Muenchen Med Wschr, 102:1419-1422.

Fulginiti, V, "Sudden Infant Death Syndrome, Diphtheria-Tetanus Toxoid-Pertussis Vaccination and Visits to the Doctor: Chance Association or Cause and Effect?", Pediatr Infect Disorder, Jan-Feb 1983, 2(1): 7-11. Baraff, LJ, et al, "Possible Temporal Association Between Diphtheria-tetanus toxoid-Pertussis Vaccination and Sudden Infant Death Syndrome", Pediatr Infect Disorder, Jan-Feb 1983, 2(1): 5-6. Reynolds, E, "Fatal Outcome of a Case of Eczema Vaccinatum", Lancet, 24 Sept 1960, 2:684-686. Apostolov. et al, "Death of an Infant in Hyperthermia After Vaccination", J Clin Path, Mar 1961, 14:196-197. Bouvier-Colle, MH, "Sex-Specific Differences in Mortality After High-Titre Measles Vaccination", Rev Epidemiol Sante Publique, 1995; 43(1): 97. Stewart GT, "Deaths of infants after triple vaccine.", Lancet 1979 Aug 18;2(8138):354-355. Flahault A, "Sudden infant death syndrome and diphtheria/tetanus toxoid/pertussis/poliomyelitis immunisation.", Lancet 1988 Mar 12;1(8585):582-583. Larbre, F et al, "Fatal Acute Myocarditis After Smallpox Vaccination", Pediatrie, Apr-May 1966, 21:345-350. Mortimer EA Jr, "DTP and SIDS: when data differ", Am J Public Health 1987 Aug; 77(8):925-926.

Vaccines and Metabolism:

Deutsch J, " [Temperature changes after triple-immunization in infant age]," Padiatr Grenzgeb 1976;15(1):3-6. [Article in German] NA, "[Temperature changes after triple immunization in childhood]," Padiatr Grenzgeb 1976;15(1):7-10. [Article in German] [Considering that the thyroid controls our Basal Metabolism, it would appear that vaccines altered (depressed) thryoid activity.]

Vaccines Altering Resistance to Disease:

Burmistrova AL, "[Change in the non-specific resistance of the body to influenza and acute respiratory diseases following immunization diphtheria-tetanus vaccine]," Zh Mikrobiol Epidemiol Immunobiol 1976; (3):89-91. [Article in Russian]

Vaccines and Kidney Disorders:

Jacquot, C et al, "Renal Risk in Vaccination", Nouv Presse Med, Nov 6, 1982, 11(44):3237-3238. Giudicelli, et al, "Renal Risk in Vaccination", Presse Med, Jun 11, 1982, 12(25):1587-1590. Tan, SY, et al, "Vaccine Related Glomerulonephritis", BMJ, Jan 23, 1993, 306(6872):248. Pillai, JJ, et al, "Renal Involvement in Association with Post-vaccination Varicella", Clin Infect Disorder, Dec 1993, 17(6): 1079-1080. Eisinger, AJ et al, "Acute Renal Failure after TAB and Cholera Vaccination", B Med J, Feb 10, 1979, 1(6160):381-382. Silina, ZM, et al, "Causes of Postvaccinal Complications in the Kidneys in Young Infants", Pediatria, Dec 1978, (12):59-61. Na, "Albuminurias", Concours Med, Mar 1964, 85:5095-5098. [vaccination adverse reactions] Oyrl, A, et al, "Can Vaccinations Harm the Kidney?", Clin Nephrol, 1975, 3(5):204-205. Mel'man Nia, "[Renal lesions after use of vaccines and sera]." Vrach Delo 1978 Oct;(10):67-9, [Article in Russian] Silina ZM, Galaktionova TIa, Shabunina NR, "[Causes of postvaccinal complications in the kidneys in young infants]." Pediatriia 1978 Dec;(12):59-61, [Article in Russian] Silina EM, et al, "[Some diseases of the kidneys in children during the 1st year of life, following primary smallpox vaccination and administration of pertusis-

diphtheria-tetanus vaccine]." Vopr Okhr Materin Det 1968 Mar; 13(3):79-80, [Article in Russian] Vaccines and Skin Disorders:

Illingsworth R, "Skin rashes after triple vaccine," Arch Dis Child 1987 Sep; 62(9):979. Lupton GP, "Discoid lupus erythematosus occurring in a smallpox vaccination scar," J Am Acad Dermatol, 1987 Oct; 17(4):688-690. Kompier, A J, "Some Skin Diseases caused by Vaccinia Virus [Smallpox]," Ned Milt Geneesk T, 15:149-157, May 1962. Weber, G et al, "Skin Lesions Following Vaccinations," Deutsch Med Wschr, 88:1878-1886, S7 Sept 1963. Copeman, P W, "Skin Complications of Smallpox Vaccination," Practitioner, 197:793-800, Dec 1966. Denning, DW, et al, "Skin Rashes After Triple Vaccine," Arch Disorder Child, May 1987, 62(5): 510-511.

Vaccines and Abcesses:

Sterler, HC, et al, "Outbreaks of Group A Steptococcal Abcesses Following DTP Vaccination", Pediatrics, Feb 1985, 75(2):299-303. DiPiramo, D, et al, "Abcess Formation at the Site of Inoculation of Calmette-Guerin Bacillus (BCG)," Riv Med Aeronaut Spaz, Jul-Dec 1981, 46(3-4):190-199.

Vaccines and Shock:

Caileba, A et al, "Shock associated with Disseminated Intravascular Coagulation Syndrome following Injection of DT.TAB Vaccine, Prese Med, Sept 15, 1984, 13(3):1900.

Other Citations:

Pathel, JC, et al, "Tetanus Following Vaccination Against Small-pox", J Pediatr, Jul 1960; 27:251-263. Favez, G, "Tuberculous Superinfection Following a Smallpox Re-Vaccination", Praxis, July 21, 1960; 49:698-699. Bonifacio, A et al, "Traffic Accidents as an expression of "Iatrogenic damage", Minerva Med, Feb 24, 1971, 62:735-740. [But officer I was just vaccinated!] Baker, J et al, "Accidental Vaccinia: Primary Inoculation of a Scrotum", Clin Pediatr (Phila), Apr 1972, 11:244-245. Edwards, K, "Danger of Sunburn Following Vaccination", Papua New Guinea Med J, Dec 1977, 20(4):203. Stroder, J, "Incorrect Therapy in Children", Folia Clin Int (Barc), Feb 1966, 16:82-90. [Agreed.] Wehrle PF, "Injury associated with the use of vaccines," Clin Ther 1985;7(3):282-284. Alberts ME, "When and where will it stop", Iowa Med 1986 Sep; 76(9):424. [When!] Breiman RF, Zanca JA, "Of floors and ceilings--defining, assuring, and communicating vaccine safety", Am J Public Health 1997 Dec;87(12):1919-1920. Stewart, AM, et al, "Aetiology of Childhood Leukaemia", Lancet, 16 Oct, 1965, 2:789-790. Nelson, ST, "John Hutchinson On Vaccination Syphilis (Hutchinson, J)", Arch Derm, (Chic), May 1969, 99:529-535. Mather, C, "Cotton Mather Anguishes Over the Consequences of His Sons Inoculation Against Smallpox", Pediatrics, May 1974; 53:756. Thoman M, "The Toxic Shot Syndrome", Vet Hum Toxicol, Apr 1986, 28(2):163-166. [Animals are not exempt from vaccination damage either!] Johnson, RH, et al, "Nosocomial Vaccinia Infection", West J Med, Oct 1976, 125(4):266-270. [Nosocomial means a disease acquired in a doctors office or hospital.]

Heed, JR, "Human Immunization With Rabies Vaccine in Suckling Mice Brain," Salud Publica, May-Jun 1974, 16(3): 469-480. Tesovic, G et al, "Aseptic Meningitis after Measles, Mumps and Rubella Vaccine", Lancet, Jun 12, 1993, 341(8859):1541. [AM has same symptoms as poliomyelitis!] Buddle, BM et al, "Contagious Ecthyma Virus-Vaccination Failures", Am J Vet Research, Feb 1984, 45(2):263-266. Freter, R et al, "Oral Immunization And Production of Coproantibody in Human Volunteers", J Immunol, Dec 1963, 91:724-729. [copro = Feces] NA, "Vaccination, For and Against", 1964, Belg T Geneesk, 20:125-130. [Is it for or against?] Sahadevan, MG et al, "Post-vaccinal Myelitis", J Indian Med Ass, Feb 16, 1966, 46:205-206. Castan, P et al, "Coma Revealing an acute Leukosis in a child, 15 days after an Oral Anti-poliomyelitis Vaccination," Acta Neurol Bekg, May 1965, 65:349-367. [Coma from vaccines!] Stickl, H, et al, "Purulent [pus] meningitides Following Smallpox Vaccination. On the Problem of Post-Vaccinal Decrease of Resistance", Deutsch Med Wschr, Jul 22, 1966, 91:1307-1310. Haas, R, et al, "Studies on the Occurrence of Viremia Following Oral Poliomyelitis Vaccination with Sabin Type I Strain LSC2ab", Deutsch Med Wschr, Mar 4, 1968, 91:385-389. Converse, J L, et al, "Control of Tissue Reactions in monkeys vaccinated with Viable Coccidioides immitis by prevaccination with killed Coccidioides immitis", J Bact, Sept 1965, 90:783-788. Motelunas, LI et al, "The Potential Epidemiological Hazard of Parental Transmission of Epidemic Hepatitis as the Result of Vaccination," Zh Mikrobiol, Nov 1965, 42:105-108. Krudusz, J, "Effect of Vaccinotherapy on the Sedimentation Rate and On the Hematocrit", Klin Oczna, 1967, 37:191-195. Pop, A, "Production of Laboratory Animals for the Production of Serums and Vaccines," Arch Roum Path Exp Mocrobiol, 1967, 23:423-430. [Animal research for vaccine production!] Espmark, A, "The Composition of Vaccines With Reference to Potentially Injurious Allergens", Lakartidningen, Nov 3, 1965, 62:3662-3667. DeRenzi, S, et al, "Damage Caused by Vaccine Therapy and Serotherapy", Clin Ter, Sept 30, 1966, 38:497-500. Lewis, J, "Iatrogenic Malaria," New Zeal Med J, Feb 1970, 71:88-89. [Malaria caused by the doctor!] Prakken, JR, "Syphilization", Nederl T Geneesk, Jun 13, 1970, 114:1019-1023. Damert, C et al, "Hygenical and Bacteriological Inspection of the Execution of Vaccination," Z Gesamite Hyg, Jul 1974, 20(7):439-442. Na, "Sibling Accidentally Vaccinates other Following Inoculation", Can Med Assoc J, Aug 4, 1973, 109:237. Opitz, B et al, "Prevention of Iatrogenic Infections Following Vaccination", Dtsch Gesundheltsw, Jun 15, 1972, 27:1131-1136. Raff, MJ, "Progressive Vaccinia (Vaccinia Gangrenosum)", J Ky Med Assoc, Feb 1973, 71:92-95. Hanissian, AS et al, "Vasculitis and Myositis Secondary to Rubella Vaccination", Arch Neurol, Mar 1973, 28:202-204. Cho, CT, et al, "Panencephalitis Following Measles Vaccination", JAMA, May 28, 1973, 224:1299. Rubin, R H, et al, "Adverse Reactions to Duck Embryo Rabies Vaccine. Range and Incidence," Ann Intern Med, May 1973, 78:643-649. Gunderman, JR, "Guillain-Barre Syndrome. Occurrence Following Combined Mumps-Rubella Vaccine", Am J Disorder Child, Jun 1973, 125:834-835. [GBS is paralysis!] Hale, MS et al, "Carpal Tunnel Syndrome Associated With Rubella Immunization", Am J Phys Med, Aug 1973, 52:189-194. Provost, A et al, "Inopportune Cattle Mucosal Diseases Associated With Rinderpest Vaccine", Bull Epizoot Afr, Dec 1972, 20:265-267. Budal, J, "Hazards of Prophylactic Vaccination," Orv Hetil, Sept 10, 1972, 113:2237-2240. Levenbuk, IS, et al, "A Morphological Study of the Harmlessness of Live Dysentery Vaccines From Streptomycin Dependent Mutants of Sh. Flexnert", ZH Mikrobiol Epidemiol Immunobiol, Feb 1972, 49:18-22.

Arnold, H, "Our Vaccination Service is Sick", Oeff Egsundheitswes, Feb 1974, 36:133-134. Spless, H, "Sterility of Vaccination Guns", Dtsch Med Wochenschr, Jun 27, 1975, 100(26):1445-1446. [Make sure the gun is sterile, because what is inside it isnt.] Redey, B, "Self-Experiments with the Ingestion of Various Bacteria", Acta Microbiol Acad Sci Hung, 1974, 21(1-2):45-62. Webster, AC, "The Adverse Effect of Environment on the Response to Distemper Vaccination", Aust Vet J, Oct 1975, 51(10): 488-490. NA, "Vaccines Made From House-Dust Mites", Drug Ther Bull, Apr 23, 1976, 14(9):35-36. [Sic!] Levaditi, JC et al, "Local Tolerance of Vaccines Adsorbed on Immuno-Stimulating Substances", Sem Hop Ther, Feb 1975, 51(2):117-118. Miller, Ta, "The Possibilities for Application of the Canine Hookworm Vaccine Technology to the Prevention and Control of Hookworm Infection and Disease in Man", In: Nuclear Techniques in Helminthology Research, Vienna, International Atomic Energy Agency , 1973. Borsche, A, "What are the Hazards of Vaccinations in Childhood?" ZFA, May 10, 1976, 52(13):666-674. Starke, G, et al, "Requirements for the Control of a Dog Kidney Cell-adapted Live Mumps Virus Vaccine", J Biol Stand, Apr 1974, 2(2):143-150. [DKC = Dog Kidney Cells] Garlick, P et al, "Stimulation of Protein Synthesis and Breakdown By Vaccination", Br Med J, Jul 26, 1980, 281(6235):263-265. Weissmann, G, "In Quest of Fleck: Science From the Holocaust", Hosp Pract, Oct 1980, 15(10):48-49.52, 54-55 passim. Williams, Go, "Vaccines in Older Patients: Combating the Risk of Mortality", Geriatrics, Nov 1980, 35(11):55-57, 63-64. Sun, M, "Compensation for Victims of Vaccines", np, Feb 27, 1981, 211(4485):906-908. Hillary, IB, et al, "Persistence of antibody 10 years after Vaccination with Wistar RA 27/3 Strain of Live Attenuated Rubella Vaccine", Br Med J, Jun 28, 1980, 280(6231):1580-1581. [RA 27/3 refers to an aborted fetus.] Frerichs, GN et al, "Estimation of Residual Free Formaldehyde in Biological Products", J Biol Stand 1980; 8(2):139-144. [Formaldehyde is a carcinogen.] Ambs, E et al, "Tuberculous Abcess of the Upper Arm With Regional Lymphadenitis as a Consequence of Injection in Two Siblings", Med Klin, July 7, 1967, 62:1050-1054. Davis, LE, "Communicating Hydrocephalus in New born Hamsters and Cats Following Vaccinia Virus infection", J Neurosurg, Jun 1981, 54(6):767-772. [Hydrocephalus is similar to brain swelling.] Simon, J et al, "A new Model of Multiple Sclerosis. Experimental Vaccinia Infection in the Monkey", Forschr Med, Nov 6, 1980, 98(41):1607-1611. [Links between vaccines and MS.] Barrie, H, "Campaign of Terror", AM J Disorder Child, Sept 1983, 137(9):922-923. [Qui tu - Vaccination - Et Brutus?] Stickl, H, "Discussion on the Most Favorable Age For Primary Smallpox Vaccination of Children", Monatsschr Kinderheilkd, Sept 1970, 118:541-544. [Answer - none!] Daugaard, J, "Adverse Effects of Vaccination. The Liability of Physicians and The objective Liability," Nord Med, Jun 1972, 87:183-184. Conteras Poza L, et al, "An Unusual Accident During Smallpox Vaccination: Intramuscular Injection of the Lymph Vaccine", Rev Sanid hig Publica (Madr) Oct 1971, 45:1017-1022. [I thought that vaccines were supposed to be given IM.] Nosov, SD, et al, "Systematization of Reactions Developing After Prophylactic Vaccination", Pediatria, Feb 1972, 51:10-15. Remsey, "Iatrogenic [Doctor -caused] Disease Caused by Vaccination", Orv Hetil, Sept 1971, 112:2245. Stickl, H, "Estimation of Vaccination Damage", Med Welt, Oct 14, 1972, 23:1495-1497. Millichap JG, et al, "Etiology and treatment of infantile spasms: current concepts, including the role of DPT immunization," Acta Paediatr Jpn 1987 Feb; 29(1):54-60. Mason, MM et al, "Toxicology and Carcinogenesis of Various Chemicals Used in the Preparation of Vaccines", np, Jun 1971, 4:185-204. Michiels, J, "Harmful Effects of Common Drugs on the Vital Apparatus. Agents of Immunity." Bull Sociologist Beige Ophtalmol, 1972, 160:467-483.

Knudsen, Rc, et al, "Difference in the Protective Immunity of the tongue and feet of Guinea Pigs Vaccinated with Foot-and-Mouth Disease Virus Type A12 Following intradermolingual and Footpad [foot and mouth]Challenge", Vet Microbiol, May 1982, 7(2):97-107. Elliman, D, "Vaccination and Professional Confusion", Br Med J, Sept 15, 1990, 301(675):551. NA, "Risk Language Preferred By Mothers in Considering a Hypothetical New Vaccine For Their Children", 1991, np. Levine, MM, "Non-target Effects of Live Vaccines: Myth, Reality and Demagoguery," Development Biol Stand, 1995, 84:33-38. Stickl, H, "No Negligence in Preventive Vaccinations", Fortschr Med, July 20, 1989, 107(21):14-15. Donaldson, AI, et al, "Transmission of Foot-and-mouth Disease by Vaccinated Cattle Following Natural Challenge", Research Vet Sci, Jan 1989, 46(1):9-14. Spier, RE, "Democratic Governments and Vaccines", Vaccine, Nov 1994, 12(15):1363. Cichutek, K, Nucleic Acid Immunizations", Vaccine, Dec 1994, 12(16):1520-1525 (23 ref). [Gene therapy could make autoimmune diseases increase.] Alexander, NJ, et al, "Contraceptive Vaccine Development", Reprod Fertil Development, 1994, 6(3):273-280. Allen, JM, "Over-the-counter Sale of Drugs and Vaccines, J AM Vet Med Assoc, Feb 1, 1995, 206(3):286. Harte, PG et al, "Failure of Malaria Vaccine in Mice Born to Immune Mothers", Clin Exp Immunol, Sept 1982 49(3):509-516. Editorial, "Are We Vaccinating without Reason?", Lakartidningen, Nov 27, 1974, 71(48):4915. Na, "The Hens Egg versus the Horses Brain: ..." 1988, np, Bonard, EC, "Is Vaccination Still Necessary?" , Rev Med Suisse Romande, Oct 1987, 107(10):781-782. Forrester, HL, et al, "Inefficacy of Pneumococcal vaccine in a High Risk Population," Am J Med, Sept 1987, 83(3): 425-430. NA, "Protection for AIDS Vaccine Suits", NJMed, May 1989, 86(5):338. NA, "AIDS Vaccines: Is Optimism Justified? Fortschr Med, Jul 20, 1989, 107(21):13. Perez Diaz R, et al, "[Post-vaccinal Pericarditis. Report of 2 Cases]", Rev Cuba Med, 1:49-54, Jul-Aug 1962. Larbre, F et al, "Fatal Acute Myocarditis After Smallpox Vaccination", Pediatrie, Apr-May 1966, 21:345-350.

Lungs: Lung Involvement in Progressive Vaccinia", West J Med, May 1981, 134(5):446-448. Liver: Liver Dysfunction and DNA Antibodies after Hepatitis B Vaccination", Lancet, Nov 5, 1994, 344(8932):1292-1293. Eyes: Occular Vaccinia: A Case Report and Review of Treatment," Med J Aust, Nov 30, 1968, 2:921-922. Occular Vaccinia," Lancet, Aug 3, 1974, 2:273-275. Vaccinations Dont Work:

Vaccinate is Not Always to Immunize", Med J Aust, May 6, 1991, 154(9):638. Polio Vaccines Has Been Largely Abandoned in the US; The other is the Leading Cause of the Disease", Science, April 1986, p 37-39.